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Abstract 
 
Restless Legs Syndrome (RLS) and Periodic Limb Movements (PLM) are common neurological 
disorders for which the underlying aetiology is not fully understood. Currently RLS and PLM are 
thought to be caused by a central deficiency of dopamine or other functional abnormalities of the 
central nervous system. The work included in this thesis investigated different new methods of 
assessing the sensory and motor features of RLS and PLM, in an attempt to extend our 
understanding of their aetiology and improve the accuracy of diagnosis of these conditions. The 
first two studies in the thesis described and characterized the sensations of RLS symptoms, and 
whether they are influenced by the presence of pain, in an English speaking South African 
population. The most frequently cited descriptors were different to those used in the current RLS 
diagnostic criteria. Inclusion of the most commonly used RLS descriptors in the diagnostic criteria 
may help to improve the accuracy of RLS diagnosis. Patients who experienced painful RLS had 
greater McGill Pain Questionnaire scores and used different terms to describe their RLS to those 
that did not have painful RLS sensations. The third project quantified the responses of the 
Hoffman and patellar reflexes in RLS patients using electromyography and kinematics. The RLS 
patients exhibited hyporeflexia in the evening compared to the morning, and compared to control 
participants. This data suggests that RLS is not the result of a global state of hyperexcitability, as 
the literature suggests, but may reflect more discrete functional abnormalities of the spinal cord. 
A diurnal variation in the patellar reflex was found, supporting the notion of circadian variations of 
spinal excitability in RLS patients. The final investigation assessed the sensory qualities (discomfort 
and pain) of RLS in conjunction with motor activity evoked by using the Suggested Immobilization 
Test. Despite rating significant levels of discomfort, the majority of the RLS patients did not exhibit 
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PLM; possibly suggesting a disconnect between the sensory and motor components of RLS. In 
conclusion, it is the major finding of this thesis that inclusion of new assessment techniques for 
the measurement of sensory and motor features of RLS and PLM provides both new insights and 
potential clinical tools enhancing our understanding of these disorders. 
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Preface  
 
Restless legs syndrome and periodic limb movement disorder are common sleep-related 
movement disorders that can have debilitating consequences for those that suffer from them. 
Despite extensive research, our understanding of these disorders and our ability to assess both the 
sensory and motor components associated with these disorders has been limited by the few 
techniques used to assess the signs and symptoms. Expansion of the available techniques could 
add significantly to the knowledge base on these disorders. The sections that follow describe how 
this body of work intends to contribute to the understanding and assessment of these disorders. 
 
Chapter 1 introduces the topic of restless legs syndrome (RLS) and periodic limb movements 
(PLM) followed by a general background to these disorders. The literature review then explores 
the current assessment of RLS and PLM investigating sensory and motor components separately, 
and then together. The rationale and objectives of the entire thesis follows. 
 
Chapter 2 and 3 include projects which use new techniques to investigate the sensory features of 
RLS. The difficulty patients experience in describing their RLS sensations has resulted in a diverse 
range of words used to describe the condition. To date these descriptors have not been fully 
categorised. Chapter 2 contains a published paper which explored the descriptors used by a 
cohort of South African RLS patients. Chapter 3 contains a paper which analyses whether the 
words selected by the same sample of RLS patients were influenced by the presence of pain. 
 
Chapter 4 looks at the motor aspects of RLS and PLM. Although the origins of RLS and PLM are 
unknown, spontaneous sensations and motor events suggest that there may be a state of spinal 
  xvii  
hyperexcitability in these patients. The published paper in this chapter evaluates the state of 
spinal excitability in RLS patients using the Hoffmann (H-reflex) and patellar reflexes.  
 
Chapter 5 interrogates the relationship between the sensory and motor features of RLS and PLM 
simultaneously using the Suggested Immobilization Test (SIT). The immobility of the SIT provokes 
RLS discomfort, possibly pain and motor restlessness and as such is an ideal candidate for 
exploring the relationship between these three features. This relationship is the focus of the paper 
(currently under review) included in this chapter. 
 
Chapter 6 summarizes and discusses each of the thesis objectives, their subsequent results and 
the contribution of these to the understanding of RLS and PLM. Suggestions for future directions 
that have emerged as a result of this research are offered. 
 
Chapter 7 includes the references used for the literature review in Chapter 1. The references for 
Chapters 2, 3, 4 and 5 are included as part of each paper. 
 
Chapter 8 includes the following appendices: The RLS questionnaire used to screen all the RLS 
patients recruited for the studies; ethical clearance certificates; all scales, questionnaires and word 
lists used in the studies incorporated in this thesis. Also included in the appendix are other 
publications that have emanated from or in conjunction with the work included in this thesis but 
do not constitute part of the thesis’ body of work. 
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“I feel as if my leg is like a candy cane 
 that is slowly being eaten from the inside out by an army of ants”.  
Quoted description of Restless Legs Syndrome and image: as provided by a patient with RLS participating in the 
studies contained within this thesis. 
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1. RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENTS   
 
Restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) are related 
neurological disorders presenting with spontaneous sensory (RLS) and motor (PLM) activity. It 
is estimated that up to 10% of the general population (Garcia-Borreguero et al., 2006) suffer 
from RLS and PLM and the consequences affect both sufferers and their partners. Although 
often occurring together, and suspected to be manifestations of the same disorder, RLS and 
PLM can present independently of each other. In the sections below I first introduce the reader 
to the concept of RLS and PLM, comment on the prevalence of these disorders and provide a 
description of their pathophysiology and circadian variations and followed by a review of 
previous work done to quantify and qualify these disorders. As will be discussed below, our 
understanding of these disorders is largely observational. Much research remains before we 
have a full understanding of, and are therefore able to effectively treat RLS and PLM.   
 
1.1. DEFINITIONS AND DIAGNOSIS 
 
The accurate diagnosis of RLS and PLM is crucial for determining prevalence statistics (as 
discussed hereafter), administering the correct treatment which has lifelong implications and 
differentiating RLS from other disorders that have similar presentations to it. The diagnosis is 
dependent on the definitions of RLS and PLM and thus it is critical that these definitions are 
correct and accurate. 
 
1.1.1. Restless legs syndrome 
 
Restless legs syndrome (RLS) is a sleep-related movement disorder characterized by an urge to 
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move in response to uncomfortable or painful sensations experienced in the legs and 
occasionally the arms. The irresistible urge to move results in voluntary leg movements to 
relieve the discomfort (Allen & Earley, 2001b). Symptoms are exacerbated in the evening 
primarily during periods of inactivity such as long distance travel, or preparing to sleep, and 
improve in the morning (Hening et al., 1999b).  
 
Published descriptions of the sensations of RLS include: “parasethesia and dysesthesia”, 
“tingling, burning, jittery, and prickling” and even as “ants or Coca-Cola in the bones and veins” 
(Earley et al., 2000b). Symptoms have also been described as painful in up to 80% of RLS 
patients (Winkelmann et al., 2000) and have been suggested to be a subclinical form of pain 
(Bentley et al., 2007). The alleviation of RLS symptoms with analgesic medications, amongst 
other treatments, further supports the concept that pain pathways are involved in the sensory 
symptoms of RLS (Hening et al., 1999a).  
 
Various different strategies (e.g. vigorous leg movements, stretching, flexing, walking, rubbing 
and massage) are employed by RLS patients to ease their discomfort. Relief comes almost 
instantaneously with such movements and symptoms can remain at bay for up to an hour after 
cessation of movement, depending on the severity of the disorder. However, because 
symptoms occur just preceding sleep, these strategies often delay sleep onset (Montplaisir et 
al., 2005).  
 
RLS was first recognized as a problem and described in the 17th century. An English physician, 
Sir Thomas Willis, described RLS symptoms in 1685 as: “Wherefore to some, when being abed 
they betake themselves to sleep, presently in the arms and legs leapings and contractions of 
the tendons, and so great a restlessness and tossing of their members ensue that the diseased 
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are no more able to sleep than if they were in a place of the greatest torture” (as cited in 
Wetter & Pollmacher, 1997). Subsequently, in the 19th century RLS was deemed a psychiatric 
disorder known as “anxietas tibiarum” owing to the bizarre descriptions of symptoms (Ekbom, 
1945). RLS was clinically accepted and formally described by Karl Ekbom in 1945 giving rise to 
the name of ‘Ekbom syndrome’ or the more commonly used ‘restless legs syndrome’ (Ekbom, 
1945; Wetter & Pollmacher, 1997; Allen & Earley, 2001b). In 1990, RLS was formally classified 
as a sleep disorder in the International Classification of Sleep Disorders (Thorpy, 1990). The 
diagnostic features, all based on patients’ symptoms, have subsequently been modified, re-
defined and validated by the International Restless Legs Syndrome Study Group (IRLSSG) in 
1995 (Walters, 1995) and later revised in 2003 (Allen et al., 2003). 
 
Currently, RLS is characterized and clinically diagnosed according to the following four essential 
criteria (Walters, 1995; Allen et al., 2003):  
 
1. “An urge to move the legs, usually accompanied or caused by uncomfortable and 
unpleasant sensations in the legs” 
2. “The urge to move or unpleasant sensations begin or worsen during periods of rest or 
inactivity such as lying or sitting” 
3. “The urge to move or unpleasant sensations are partially or totally relieved by 
movement, such as walking or stretching, for at least as long as the activity continues”  
4. “The urge to move or unpleasant sensations are worse in the evening or night than 
during the day, or only occur in the evening or night” 
 
Positive answers to all four of these questions are required for the diagnosis of RLS. Recently 
the four diagnostic criteria of RLS have been summarized into a single question for rapid 
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screening in a neurological clinical practice as follows: “When you try to relax in the evening or 
sleep at night, do you ever have unpleasant, restless feelings in your legs that can be relieved 
by walking or movement?” (Ferri et al., 2007).  
 
In addition to the essential criteria for the diagnosis of RLS, there are supportive non-essential 
clinical features that may be useful in resolving uncertainties regarding the diagnosis. These 
supportive features are: a positive family history of RLS; positive response to dopaminergic 
treatment and the presence of PLM (during wakefulness or sleep) (Allen et al., 2003). First 
degree relatives are 3-5 times more likely to experience RLS than people without RLS (Allen et 
al., 2003). Initially, many RLS sufferers exhibit a positive therapeutic response to treatment 
with either L-dopa or dopamine-receptor agonists. As previously noted, PLM are commonly 
associated with RLS and have a suspected common aetiology and therefore their appearance 
may confirm the diagnosis of RLS (Allen et al., 2003; Trenkwalder & Paulus, 2010). 
Complicating the accurate diagnosis of RLS is that there are different RLS phenotypes. 
 
1.1.1.1. Restless legs syndrome phenotypes 
 
There are various classifications and subgroups proposed for RLS which may suggest that RLS is 
a heterogeneous disorder. RLS patients can be classified according to whether their RLS is 
idiopathic or secondary, early or late onset or familial or sporadic. According to Allen and 
Earley the aetiology of RLS may differ between groups with different expressions of the 
disorder, thus making it difficult to accurately define (Allen & Earley, 2000).  
 
The most accepted distinction is between primary and secondary RLS. Primary or idiopathic 
RLS involves RLS symptoms in the absence of other medical problems known to be associated 
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with RLS. The secondary or symptomatic form of RLS is essentially ‘acquired’, occurring in 
association with other conditions such as iron deficiency anaemia, uraemia, neuropathies, 
pregnancy and renal failure (Wetter & Pollmacher, 1997; Patrick, 2007; Whittom et al., 2007). 
Despite the underlying differences causing the RLS, there do not appear to be any differences 
in the physical presentation between primary and secondary RLS. 
 
RLS used to be described as a disorder affecting ‘older’ people (Allen & Earley, 2001b). 
Subsequent research has indicated that there are two distinct phenotypes, namely: early and 
late onset (Walters et al., 1996). The critical onset age (years) quoted in the literature ranges 
from 20’s to mid 40’s depending on methods used to determine age-of-onset (Allen & Ritchie, 
2008). The cut-off between early and late onset is determined as the trough between the 
peaks of the bimodal distribution when the onset of RLS is plotted as a frequency distribution. 
Earlier studies set the cut-off for late onset at 45 years (Allen & Earley, 2000; Polydefkis et al., 
2000) but subsequent reports indicate that the division between early and late onset appears 
in the mid 30’s (Whittom et al., 2007; Allen & Ritchie, 2008). Various problems complicate the 
determination of age-of-symptom-onset. Accurate recall of the symptoms can be difficult to 
determine and may reflect a change in the severity of the disorder rather than a variance in 
age-of-symptom-onset (Allen & Ritchie, 2008). Additionally, RLS in children is often 
misdiagnosed as attention deficit hyperactivity disorder (ADHD) or growing pains (Montplaisir 
et al., 2005). Early onset RLS is more slowly progressing, more likely to have a familial 
component, has no relationship to iron status, and has a female preponderance when 
compared to late onset RLS (Allen & Earley, 2000; Winkelmann et al., 2002; Hanson et al., 
2004; Whittom et al., 2007). 
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Another division amongst RLS patients is the split into familial, those having first degree 
relatives with RLS; and sporadic, with no close relatives suffering from RLS. Approximately 60-
65% of RLS patients indicate a positive family history (Winkelman, 2006). There may be a 5-fold 
risk increase for first degree relatives of patients with early onset RLS (Allen & Ritchie, 2008). A 
positive family history of the disorder is often used as supporting confirmation in the diagnosis 
of RLS (Montplaisir et al., 2005). Genetics studies to locate specific genes that are responsible 
for RLS are still in their infancy. Various candidate genes have been identified and investigated, 
and thus far it has been suggested that the genetic component is complex, possibly with 
multiple genes playing a role, with the genes for early and late onset RLS possibly occurring on 
different chromosomes (Zucconi et al., 2007).  
 
The different phenotypes of RLS indicate that there may be multiple factors contributing to this 
disorder. Looking at other components of the disorder may help differentiate whether it is a 
homogenous or heterogeneous disorder.  
 
1.1.2. Periodic limb movements 
 
Involuntary movements, known as periodic limb movements (PLM), are commonly associated 
with RLS. According to Allen and Earley (2001) 85% of patients with RLS also express PLM, 
possibly suggesting a similar origin for the two.  
 
PLM are characterized by involuntary leg movements or muscle twitches occurring mainly 
during sleep (PLMS) but which can also occur during restful wakefulness (PLMW). A further 
distinction is made for periodic limb movement disorder (PLMD) which is defined as “… a 
clinically significant sleep disruption from PLMS that cannot be accounted for by another sleep 
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disorder” (Allen & Earley, 2001b). In the literature, PLMD is generally referred to as PLM, 
despite PLM actually describing a sign of PLMD. For consistency with the literature, I will refer 
to the disorder as PLM with recognition that the presence of PLM does not imply the disorder. 
 
PLM were first noted in 1943 by Allison (as cited in Coccagna et al., 2004) and were originally 
called ‘nocturnal myoclonus’ by Symonds in 1953, who incorrectly assumed that they were a 
form of epilepsy (Symonds, 1953). In the early 1980s the limb movements were characterized 
and called “PLM” by Coleman (Coleman, 1982).  
 
The uni- or bilateral repetitive leg movements are characterized by extension of the big toe; 
partial dorsiflexion of the ankle, the knee and occasionally the hip (Coleman et al., 1980). Smith 
(1985) reported, based on video image analysis, that PLM during sleep resembled the Babinski 
sign (Smith, 1985). The Babinski sign, upon plantar stimulation, is characterised by dorsiflexion 
of the big toe and fanning of the other toes (Van Gijn, 1996). The particular sequence of muscle 
activations of PLM prompted Lugaresi to conclude that PLM resemble the flexor withdrawal 
reflex (cited in Vetrugno et al., 2007a). 
 
PLM are diagnosed by an increase in activity on surface electromyography (EMG) of either one 
or both of the anterior tibialis muscles, the muscle most commonly involved in PLM (Hening, 
2004a). Polysomnography (PSG) is the gold standard method used in the basic diagnosis of 
PLM, particularly PLMS. PSG is required to rule out movements related to respiratory events, 
and differentiate PLMS from other possible sleep disorders (Hening, 2004a). 
 
According to the World Association of Sleep Medicine (WASM) (Zucconi et al., 2006), the 
defining criteria, based on Coleman’s original observations, for pathological leg movements 
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involved in a PLM sequence consist of electromyographic activations fulfilling the following 
parameters:  
 
1. The EMG amplitude increases by at least 8μV above baseline 
2. Each individual burst has a duration of 0.5 to 10 seconds 
3. Each EMG activation must be separated by at least 5 but not more than 90 seconds. 
4. There are four or more EMG bursts meeting the above criteria.  
 
Hundreds of these PLM, clustering into episodes, may be present during sleep and are 
generally more numerous in, but not exclusive to, the first half of the night (Wetter & 
Pollmacher, 1997). The leg movements may or may not be associated with arousals depending 
on the duration of the movement and the patient’s sleep stage (Wetter & Pollmacher, 1997). 
The severity of the PLM is determined by calculating the number of PLM per hour of total sleep 
time, termed the PLM index (Wetter & Pollmacher, 1997; Hornyak et al., 2006). A PLM index of 
greater than 5 is considered pathological (Hornyak et al., 2006). PLM are commonly associated 
with various other sleep disorders including sleep apnoea, rapid eye movement (REM) sleep 
behaviour disorder, insomnia, hypersomnia, and narcolepsy (Vetrugno et al., 2007a). PLM are 
also known to be present in association with non-sleep related disorders such as congestive 
heart failure, spinal cord injury, end-stage renal failure and hypertension (Wetter & 
Pollmacher, 1997; Vetrugno et al., 2007a).  
 
PLM, however, are also known to manifest in healthy individuals, particularly the elderly, with 
between 30% and 50% of people over the age of 60 years having a PLM index greater than 5 
without associated RLS or other sleep disorders (Ancoli-Israel et al., 1985; Dickel & Mosko, 
1990).     
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1.2. PREVALENCE AND IMPORTANCE OF RESTLESS LEGS SYNDROME AND PERIODIC 
LIMB MOVEMENTS 
 
To date epidemiological studies of RLS have primarily focused on Western (mainly Caucasian) 
societies with less attention paid to non-Western populations and specific groups commonly 
associated with the presence of RLS. Garcia-Borreguero et al (2006) extensively reviewed the 
epidemiological studies of RLS from 1993 to 2005 and reported that the most common 
prevalence is between 2.5 and 10% of the general population (Garcia-Borreguero et al., 2006), 
making it one of the most common neurological disorders (Cervenka et al., 2006). A recent 
paper examining previous (pre 2010) epidemiological studies suggests that the frequency of 
RLS increases as a function of increasing distance from the equator, particularly in North 
America and Europe (Koo, 2011). RLS is more prevalent in the elderly (two to three fold 
increase from young adults to those over 60 years old) and with an apparent gender bias of 2:1 
(female: male) across all ages (Garcia-Borreguero et al., 2006).  
 
Non-western population studies are limited and report a wide range of prevalence of RLS in 
comparison to Western based studies, however methodological issues bring the validity of 
some of these findings into question (Garcia-Borreguero et al., 2006). The prevalence of RLS in 
the general population of Asian countries that have been studied has a broad range, between 
0.9% and 12.0% (South Korea); 1.0% and 11.4% (Japan); 1.6% (Taiwan); and 2.1% (India) 
(Ohayon et al., 2012). The higher values observed in these studies were based on research 
using a single screening question (not defined by the IRLSSG diagnostic criteria) and thus may 
not be an accurate reflection of the prevalence of RLS in these populations. Very few studies 
have been conducted in native South American and African populations. One study in Ecuador 
reported a low prevalence of RLS between 0.8% and 3.2% (Ohayon et al., 2012), whereas 
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another in Argentina reported a much higher prevalence of 20.2% (Persi et al., 2009). One 
population based study in Northern Tanzania reported an extremely low prevalence of 0.01% 
however the authors did indicate this may not be a true reflection of the population as 
“preoccupation with daily survival” may have distracted the people in this remote, rural 
community from noticing and reporting the non-life threatening symptoms of RLS (Winkler et 
al., 2010). A small study in South Africa indicated a prevalence of RLS in 23.3% of an aged 
population (Venter et al., 2001). This study was, however, conducted in a presumably 
Caucasian dominant community and may not reflect the true population dynamics of the 
country (an ethnic breakdown of the sample was not reported). A study of individuals of 
African American ancestry reported a prevalence of 4.7% in their sample (Lee et al., 2007). 
 
The IRLSSG established diagnostic criteria for RLS in 1995, but some epidemiological studies do 
not use these criteria or were conducted before the criteria were established and thus the 
diagnosis of RLS may vary between studies, which itself may confound attempts to try 
accurately describe prevalence. Further confounding factors in the epidemiological studies are 
the lack of distinction between primary and secondary RLS. Acquired RLS has a higher 
prevalence in various metabolic, neurological and other conditions. There are specific medical 
situations where the prevalence of RLS is greater, for example: during pregnancy between 19% 
(Goodman et al., 1988; Suzuki et al., 2003) and 26% (Manconi et al., 2004) of women 
experience RLS and between 7% (Bhowmik et al., 2003) and 83% (Holley et al., 1991) of 
patients in end stage renal failure also have RLS. The RLS diagnostic criteria do not differentiate 
between different RLS phenotypes and therefore the prevalence data may be an inaccurate 
reflection of the population.    
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The prevalence of PLMS is particularly difficult to ascertain because sufferers are often 
unaware of the condition and rely on bed partners to report these nocturnal leg activities. 
Unlike RLS that can be evaluated by questionnaires using the diagnostic criteria, the 
assessment of PLMS is largely and most accurately dependent on EMG in conjunction with PSG 
based on the WASM scoring criteria (Zucconi et al., 2006). Scofield et al. (2008) performed PSG 
on a sample of 592 American individuals and discovered a prevalence of PLMS of 7.6% in this 
population. Predominantly more Caucasian than African American individuals (9.3% vs. 4.3%) 
presented with >5 PLMS per hour (Scofield et al., 2008). PSG recordings on 100 elderly people 
showed that up to 50% of the group had PLM without an associated sleep disorder (Dickel & 
Mosko, 1990). High costs, and the practicalities of EMG and PSG measurements, hinder large 
scale epidemiological studies.  
 
Telephone interview surveys and actigraphy (measure of limb acceleration) studies offer 
alternate, much more practical methods facilitating large scale epidemiological studies. Despite 
the advantages of utilizing telephonic and actigraphy for determining prevalence statistics, 
there have been relatively few studies using these techniques, possibly related to 
methodological problems. The largest prevalence study to date (n=18980), by telephone 
interview survey using the International Classification of Sleep Disorders criteria found a 
prevalence of 3.9% in Europe (Ohayon & Roth, 2002). Pathological PLMS (PLM index greater 
than 5) were present in 37% of volunteers in a small actigraphy study conducted in the United 
Kingdom (Morrish et al., 2002). Despite the high co-morbidity between RLS and PLM there 
does appear to be a difference in the reported prevalence of RLS and PLM. Whether this is due 
to methodological errors in determining the epidemiology or indicates that perhaps these are 
independent disorders is yet to be determined.  
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The clinical significance and impact of RLS and PLMS is unclear, some patients cite severe sleep 
complaints and associated fatigue where others report inconsequential symptoms. The 
sensations and relief-seeking leg movements of RLS generally occur just prior to sleeping or can 
awaken patients from their sleep. This frequently delays sleep onset, causes sleep disruption 
and subsequent excessive daytime sleepiness, and even depression (Allen & Earley, 2001b). 
The total sleep time of RLS patients has been shown to be remarkably reduced with a mean 
sleep efficiency of only 50% (compared to over 80% in healthy sleepers) (Allen & Earley, 2000). 
Other studies have shown that RLS patients do not report fatigue and daytime sleepiness 
(based on Epworth Sleepiness Scale scores) despite significant levels of sleep loss (Bassetti et 
al., 2001; Saletu et al., 2002; Gamaldo et al., 2009). Differences in RLS severity, patient ages, 
and RLS phenotypes (e.g. age of RLS onset) could possibly account for the different outcomes. 
If RLS is a heterogeneous disorder, then differences in the patient samples could lead to 
conflicting results.   
 
Besides the sleep related consequences of RLS and PLM, or possibly even related to them, 
there are also reports that these patients are at risk of cardiovascular problems, depression 
and anxiety disorders. The sleep fragmentation and sleep deprivation accompanying RLS and 
PLM puts these patients at greater risk of developing cardiovascular problems possibly due to 
sympathetic nervous system hyperactivity (Winkelman et al., 2008). The association of RLS and 
PLM with cardiovascular risk factors makes these two disorders a far greater public health 
problem than previously recognised (Winkelman et al., 2008; Schlesinger et al., 2009; Walters 
& Rye, 2009).  
 
Evidence from patients with insomnia indicates a high prevalence of depression associated 
with the reduced sleep quality thus it follows that RLS patients that may have delayed sleep 
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onset and decreased sleep efficiency could also be at risk of depression (Allen & Earley, 2001b; 
Tsuno et al., 2005). Depressive and anxiety disorders have also been shown to have an 
increased prevalence amongst RLS patients (Earley & Silber, 2010).  Although treatment for the 
symptoms of RLS and PLM is currently available, we still lack a full understanding of these 
disorders and their underlying pathophysiology. 
 
1.3. AETIOLOGY OF RESTLESS LEGS SYNDROME AND PERIODIC LIMB MOVEMENTS 
 
The aetiology of RLS and PLM is yet to be fully resolved and there are numerous potential 
theories. A detailed exploration of all the theories concerning the aetiology of RLS and PLM 
would require extensive study beyond the scope of this literature review. A brief overview of 
the main theories concerning the aetiology of RLS and PLM follows hereafter, with particular 
reference to those of relevance to the current thesis.  
 
The combined sensorimotor nature of RLS and PLM suggests that there is either an 
abnormality in a single region where both sensory and motor areas coincide or there may be 
many regions involved in the pathogenesis of these disorders, extending from the limbs 
themselves to the cerebral cortex. The circadian bound nature of the symptoms also needs to 
be considered in determining the pathophysiology of RLS and PLM. Various different 
chromosomes have possible links to RLS, which might support a multifactorial pathophysiology 
(Winkelman, 2006).  
 
One theory that does seem to account for all the features of the diagnostic criteria is that of 
decreased dopamine in the central nervous system. Dopamine plays a regulatory role in both 
sensory and motor functions (Winkelman, 2006).  Traditionally the research approaches used 
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to explore the dopamine hypothesis of RLS and PLM have included: study of the role of the 
neurotransmitter, dopamine, itself; identification of specific structures or functions of the 
nervous system, cortical and subcortical, particularly related to the dopaminergic system 
(identified in Figure 1) and iron metabolism (Allen & Earley, 2001b). The involvement of each of 
these research approaches, and their relation to one another, in the development of our 
understanding of the pathogenesis of RLS and PLM will be discussed below and will lead into 
the concept of central sensitization followed by considerations of the circadian variations of 
symptoms.  
 
 
Figure 1: Areas of the CNS putatively implicated in the pathogenesis of RLS and PLM (Trenkwalder & 
Paulus 2010) 
 
 
1.3.1. Abnormalities of the dopamine system  
 
The serendipitous discovery that RLS and PLM respond exceptionally well to dopamine agonist 
treatment indicates that RLS and PLM may be caused by an abnormality of the dopaminergic 
Trenkwalder, C. & Paulus, W. (2010) Restless legs syndrome: pathophysiology, clinical presentation and management 
Nat. Rev. Neurol. 6, 337-346 
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linked pathways. The dysfunction is suspected to be central rather than peripheral because 
dopamine antagonists that can cross the blood-brain barrier exacerbate RLS symptoms, 
whereas those that cannot cross the blood-brain barrier produce no noticeable symptoms 
(Winkelman, 2006). Evidence suggests that abnormalities in the dopaminergic linked pathways, 
reduced dopamine uptake and binding, and/or hypoactive dopaminergic neurotransmission 
are possible causes of the symptoms of RLS and PLM (Cervenka et al., 2006; Winkelman, 2006). 
 
Figure 2 represents the dopamine synthetic and metabolic pathway and shows relevant 
relationships with factors that are regulated by or regulate dopamine and are featured in the 
RLS and PLM literature. Homovanillic acid (HVA) and 5-hydroxyindolacetic acid (5H1AA) are 
cerebrospinal fluid (CSF) monoamine metabolites. HVA is the major dopamine metabolite and 
is a measure of dopamine metabolism and 5H1AA is the main metabolite of serotonin. The 
ratio between them (HVA: 5H1AA) is an indication of the serotonergic modulation of 
dopaminergic activity. 3-ortho-methyldopa (3OMD) is the product of a minor alternative 
pathway for the metabolism of L-dopa (L-dihydroxyphenyalanine), the pre-cursor molecule of 
dopamine. 
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Figure 2: Schematic diagram of the dopamine synthesis and breakdown pathway including 
interactions with relevant inputs and outputs that may play a role in the pathophysiology of RLS and 
PLM. The dotted red lines indicate inhibition. *The conversion of tyrosine to L-Dopa by the iron 
dependent tyrosine hydroxylase is the rate limiting enzymatic step. 
 
Despite the positive response following dopaminergic treatment indicating that there is an 
abnormality of the dopaminergic system in RLS and PLM patients, there is relatively little 
evidence of a dopaminergic deficiency in these patients. A study conducted in a single patient 
with severe RLS in 1985 reported high CSF dopamine and HVA concentrations (Montplaisir et 
al., 1985). Subsequently, focusing specifically on factors directly involved in the metabolism of 
dopamine (represented in Figure 2), CSF levels of HVA, 3OMD, levodopa and serotonergic 
metabolites were no different between patients with RLS and control subjects (Earley et al., 
2001, Stiasny-Kolster et al., 2004d). Further research focusing on the CSF levels of dopamine 
and its metabolites has been conducted however these studies were done in the context of the 
circadian variation and are discussed in section 1.3.4. Neuroimaging studies of specific 
dopaminergic pathways have also provided evidence of the abnormalities of the dopamine 
system in RLS and PLM patients. 
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Both the A9 (nigrostriatal) and A11 spinal dopaminergic systems have been implicated in the 
pathophysiology of RLS given their involvement in movement generation and circadian 
rhythms respectively. The nigrostriatal A9 cell group is one of the major ascending 
dopaminergic inputs to the striatum and is suspected to be involved in the initiation of 
voluntary movement (Kandel et al., 2000). Degeneration of these pathways with reduced 
dopamine is associated with the tremors, rigidity and akinesia characteristics of Parkinson’s 
disease (Rye, 2004). Therapeutic agents used to treat Parkinson’s disease have also been 
successful in the alleviation of RLS symptoms. The major source of dopamine in the basal 
ganglia (responsible for control of motor function) is the A9 nigrostriatal cell group (Vetrivelan 
et al., 2010). Loss of dopamine in the A9 pathway may result in involuntary movements (Obeso 
et al., 2002) such as those seen in PLM and thus this pathway is implicated in the aetiology of 
PLM.  
 
There is relatively little consistent evidence that the A9 pathway is affected in patients with RLS 
and PLM. Staedt and colleagues originally reported a deficiency in striatal D2 dopamine 
receptors (Staedt et al., 1993; Staedt et al., 1995). Various neuroimaging studies using SPECT 
and PET have examined receptor binding potentials of radioligand dopamine D2-receptors to 
explore processing of sensory stimuli. Striatal D2-receptor binding potentials were reported to 
be increased (Cervenka et al., 2006), decreased (Turjanski et al., 1999; Michaud et al., 2002c) 
and no different (Eisensehr et al., 2001; Tribl et al., 2004) in RLS patients compared to control 
subjects. Striatal dopamine transporter (DAT) has also been shown to be normal (Eisensehr et 
al., 2001; Michaud et al., 2002c), downregulated (Earley et al., 2011) and upregulated (Kim et 
al., 2012) in RLS patients compared to control subjects. Nigrostriatal presynaptic dopaminergic 
function has also been shown to be normal (Trenkwalder et al., 1999b) and hypofunctional 
(decreased F-dopa uptake) (Turjanski et al., 1999; Ruottinen et al., 2000) in RLS patients 
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compared to control subjects. Many of these neuroimaging studies had small sample sizes and 
were conducted during the symptom free daytime period. Taking into account possible 
methodological problems, it appears that there may be dopaminergic hypofunction in RLS 
patients however further research of the role of the nigrostriatal pathway in the aetiology of 
RLS and PLM is required.  
 
Dysfunction of the A11 diencephalospinal dopaminergic pathway, the only significant 
descending spinal dopamine system, has also been implicated in the pathophysiology of RLS. 
Abnormality in the spinal cord could produce RLS and PLM sensorimotor symptoms as the 
spinal cord is the primary input of sensory afferents and final output stage of motorneurones 
(Paulus & Schromburg, 2006). The A11 system is involved in sensorimotor integration and 
antinociception at the level of the spinal cord (Barraud et al., 2010). Clemens et al (2006) 
proposed two mechanisms whereby the A11 pathway hypofunction may result in alterations of 
the peripheral sensory information that reaches the thalamus and ultimately the cortex 
(Clemens et al., 2006). The first hypothesis suggests that peripheral sensory input is altered at 
the level of the spinal cord as the A11 pathway is known to modulate sensory input to the 
dorsal horn. A loss of dopamine would result in abnormal sensory information being sent to 
the thalamus. The same group proposed an alternative mechanism which also occurs at the 
level of the spinal cord, but involves the A11 pathway modulation of sympathetic output to the 
muscles. With hypofunction of the A11 pathway, there will be an increased sympathetic 
outflow to the periphery, changing the sensory information returned to the spinal cord 
(Clemens et al., 2006). The A11 dopaminergic cells are also involved in pain control (dopamine 
inhibits neurons in the dorsal horn where pain information is received). Dysfunction of this 
pathway may disturb the gate control mechanism for pain and therefore allow transmission of 
the painful symptoms of RLS (Moller et al., 2010). Also, further supporting the argument in 
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favour of A11 pathway involvement in the aetiology of RLS and PLM is that the A11 pathway is 
anatomically connected to the suprachiasmatic nucleus which is involved in the control of 
circadian rhythms (Trenkwalder & Paulus, 2004).  
 
Contrary to the prevalent idea that all RLS patients have a dopamine deficiency, Allen et al 
(2009) suggest that in fact RLS patients with abnormally elevated CSF 3OMD and HVA 
concentrations have increased dopamine synthesis and tyrosine hydroxlase expression 
associated with a significant deficiency of central iron (Allen et al., 2009). These RLS patients 
with abnormally increased CSF 3OMD levels also presented with significantly more PLMS/hour 
than RLS patients with normal 3OMD levels suggesting the former group had a greater severity 
of RLS. The RLS patients with normal 3OMD levels exhibited CSF HVA concentrations and 
ferritin levels that were significantly slightly lower than control subjects. The authors do 
suggest that there may be a biphasic pattern of dopaminergic status related to the severity or 
phase of the disorder. There may be increased production of dopamine in patients with severe 
RLS symptoms (more PLM and discomfort) associated with decreased concentrations of central 
iron and patients with less severe RLS symptoms may possibly have decreased dopamine 
concentrations and less central iron loss (Allen et al., 2009).  
 
This pattern of dopaminergic status, where RLS symptoms will present if dopamine 
concentrations are too low or too high, is similar to the dopamine paradox of symptom 
augmentation demonstrated in Figure 3. Kim and colleagues propose a similar idea in their 
recent paper where they suggest that RLS may be due to dopaminergic dysregulation, rather 
than simple increased or decreased dopaminergic neurotransmission. They suggest that 
upregulation of dopaminergic neurotransmission may cause severe RLS whereas 
downregulation may result in less severe RLS (Kim et al., 2012). 
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Figure 3: The U-shaped dopamine paradox curve. RLS symptoms present as a function of the 
dopamine concentration. Drug naive patients, who have less than optimal dopamine concentrations, 
occur on the left of the curve. Patients on optimal treatment, where dopamine concentrations are 
within the normal range and do not present with RLS symptoms, occur in the middle. In patients with 
symptom augmentation on the right of the curve, there is an exacerbation of symptoms with an 
abundance of dopamine (Paulus & Trenkwalder, 2006). 
 
There does not seem to be a consistent pattern of abnormality in the dopaminergic systems 
and most of the evidence supporting dopaminergic involvement is based on pharmacological 
studies with a lack of conclusive physiological data. The conflicting literature regarding the 
dopaminergic system may reflect different phases of the disorders progression, differences in 
underlying pathology or heterogeneity within patient samples (for example disease severity, 
family history and age-of-onset) which may complicate the results. Many of the studies 
focusing on the role that dopamine plays in RLS and PLM were conducted during symptom free 
daytime periods, which may explain some of the conflicting literature and emphasize the 
importance of taking into account the circadian variation of symptoms (discussed in section 
1.3.4).   
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1.3.2. Iron deficiency 
 
Iron appears to play a central role in the dopaminergic aetiology of RLS. The conversion of 
tyrosine to dihydroxyphenyalanine (DOPA) by the enzyme tyrosine hydroxylase (the rate 
limiting enzyme), in the dopamine pathway, is iron dependent (iron is a cofactor for the 
hydroxylation of tyrosine) (Figure 2). Iron is also reported to be involved in the regulation of 
dopamine D2 binding sites and iron deficiency is accompanied by a significant reduction in the 
D2 receptor binding capacity (Ashkenazi et al., 1982; Beard, 2003). The greatest iron 
concentrations in the brain are found primarily in components of the basal ganglia (substantia 
nigra, globus pallidus, and putamen) and the red nucleus (Krieger & Schroeder, 2001), areas 
which have been implicated in the pathophysiology of RLS and PLM.  
   
Evidence supporting the role that iron plays in the pathophysiology of RLS and PLM includes 
studies using neuroimaging techniques, autopsy data, analysis of CSF and serum levels of 
ferritin and transferrin. In the body iron is bound to the proteins, ferritin and transferrin, to 
facilitate storage and transportation in a non-reactive form. Ferritin concentration is the best 
serum marker of iron stores. Transferrin is an iron binding blood plasma protein that is 
responsible for transferring iron from the gut or storage sites to other sites in the body or 
within the central nervous system (CNS) (Patrick, 2007). Measuring ferritin and transferrin 
concentrations provide a more accurate reflection of the overall iron status of the body than 
measuring the highly variable serum levels of iron alone.  
 
Impaired iron metabolism and reduced iron concentrations have been detected in RLS patients 
particularly in the substantia nigra and the putamen measured using both neuroimaging 
techniques and immunohistochemical evaluation of brain tissue harvested during autopsy 
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(Allen et al., 2001; Connor et al., 2003; Baier & Trenkwalder, 2007; Patrick, 2007). Also, serum 
ferritin levels (Allen, 2004) have been negatively correlated with the severity of RLS symptoms 
(O'Keeffe et al., 1994; Sun et al., 1998; Clardy et al., 2006). Disorders or conditions associated 
with iron deficiency, e.g. anaemia, pregnancy and end stage renal disease, have a high 
prevalence of RLS. Moreover, treating the underlying iron deficiency is known to result in 
resolution of the RLS symptoms (Allen & Earley, 2007).  
 
RLS patients exhibit an altered brain iron acquisition profile (Connor et al., 2011). In epithelial 
cells extracted during autopsy from the choroid plexus (the site of CSF production) of RLS 
patients, iron and ferritin staining were reduced whereas levels of transferrin and its receptor 
were upregulated (Connor et al., 2011). CSF extracted via lumbar puncture from RLS patients 
has also been shown to have decreased ferritin and increased transferrin levels compared to 
controls (Earley et al., 2000a; Mizuno et al., 2005). Increased transferrin levels are indicative of 
decreased iron availability. The endothelial cells of the blood brain barrier express the 
transferrin receptors and thus upregulation of these receptors may be to increase the central 
uptake of iron. There was also reduced activity of iron regulatory protein and decreased 
transferrin levels in the microvasculature derived from the motor cortex suggesting that there 
are problems of brain iron acquisition in RLS patients (Connor et al., 2011).  
 
Overall, the data supports the concept that there is a brain iron deficiency in RLS patients. 
Imaging studies of the dopaminergic pathways which report decreased D2 binding are 
consistent with the insufficient brain iron hypothesis, and thus, some but not all of the 
dopamine studies are aligned with the hypothesis that central iron deficiency can account for 
the dopaminergic dysfunction reported for RLS patients. Further research is required to 
determine the relationship between iron and dopamine in the aetiology of RLS and PLM. 
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1.3.3. Central sensitization 
 
If the hypothesis of insufficient brain iron in RLS and PLM patients which results in reduced 
dopaminergic function is true, this would then impact the A11 diencephalospinal pathway, the 
only significant descending spinal dopaminergic system. These descending pathways modulate 
the activity of spinal interneurones (both inhibitory and excitatory) and particularly those 
pathways using monoamines (for example dopamine depresses monosynaptic reflexes) 
(Clemens & Hochman, 2004). Thus, a deficiency of dopamine would alter the spinal cord 
function resulting in increased excitability of involuntary motor reflexes (central sensitization).  
 
Central sensitization is caused by increased neuronal membrane excitability or reduced 
neuronal inhibition. Decreases in stimulation thresholds result in previously subthreshold 
inputs becoming stimulatory and thus there is an increased output of action potentials 
(Latremoliere & Woolf, 2009). Spontaneous action potentials will occur if the resting 
membrane potential is depolarised above the threshold potential. The spontaneous nature of 
the sensory and motor features of RLS and PLM has directed investigators towards the concept 
that these features may arise due to central sensitization. In particular, hyperexcitability of the 
spinal cord (central sensitization) has been proposed as the final common pathway responsible 
for the sensorimotor features of RLS and PLM and has some supporting evidence in pain and 
reflex studies.  
 
Central sensitization presents, in some circumstances, as hyperalgesia (increased sensitivity to 
pain). Hyperalgesia can be tested using Quantitative Sensory Testing (QST). Some authors have 
shown that the function of the peripheral nociceptive pathways is normal in RLS patients (Han 
et al., 2007; Tyvaert et al., 2009) whilst CNS pain processing is amplified by RLS (Han et al., 
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2007; Tyvaert et al., 2009; Edwards et al., 2011). Stiasny-Kolster et al. (2004) showed that RLS 
patients exhibit static mechanical hyperalgesia in response to punctate mechanical stimuli 
(Stiasny-Kolster et al., 2004c). Schattschneider et al. (2004), using quantitative thermotest 
assessments, found that temperature perception in both idiopathic and secondary RLS was 
impaired but there were no differences in hot or cold pain thresholds between the two groups. 
Also, quantitative measures of the peripheral C fibre axon reflex showed significantly reduced 
flare responses and vasodilation in secondary but not idiopathic RLS indicating possible small 
fibre neuropathy in the former group (Schattschneider et al., 2004). Thus they demonstrate 
that in idiopathic RLS the altered temperature perception is not due to a peripheral mechanism 
but rather an impairment of central somatosensory processing.  
 
Areas of brain activation during RLS sensory discomfort (i.e. areas that are affected by RLS and 
PLM) have been assessed using various neuroimaging techniques (magnetic resonance 
imaging, single photon emission computed tomography, positron emission tomography and 
voxel-based morphometry). The identified brain areas of interest are similar to those areas 
associated with pain, and include the thalamus, cortex (various sites), cerebellum, 
hippocampus, amygdala and basal ganglia (Tracey, 2005). It has been further proposed that 
there is a deficiency in endogenous opioid inhibition of ascending spinothalamic pathways 
resulting in altered processing at the thalamic level and the feeling of abnormal sensations 
(Walters et al., 2009). The identification of these areas may further support the notion that 
pain pathways are associated with the pathophysiology of RLS and PLM. However, further 
research is required to elucidate the exact contribution of the pain pathways to RLS and PLM. 
 
Also of central (spinal) origin is the concept that PLM are possibly generated by the spinal 
central pattern generators (CPG) for gait. CPGs generate rhythmic, repetitive and stereotyped 
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movements (Lacquaniti et al., 1999) which are characteristic traits of PLM. Increased 
excitability of the spinal cord could possibly trigger spontaneous movements such as those 
seen in PLM. CPGs can also act independently of supraspinal control (Lacquaniti et al., 1999). 
The occurrence of PLM in patients following spinal cord injury indicates that their origin would 
have to be at the level of the spinal cord, making hyperexcitability of CPGs an attractive 
possibility for the creation of PLMS (Vetrugno et al., 2007a).  
 
Examining patients with spinal cord lesions, a condition of known spinal hyperexcitability due 
to interruption of descending supraspinal inhibition (Sheean, 2002), for evidence of RLS and 
PLM also contributes to the idea that these syndromes are generated from a spinal origin. 
Disorders involving upper motor neuron lesions, that isolate the spinal cord from supraspinal 
inhibitory control, are classical examples of spinal hyperexcitability (Nielsen et al., 2007). 
Quatrale et al (2003) proposed sleep related disinhibition of descending central inhibitory 
pathways as a possible mechanism of spinal hyperexcitability in RLS and PLM patients and thus 
it would be expected that there would be commonality of spinal excitability between RLS and 
spasticity (as seen in spinal cord lesion patients) (Quatrale et al., 2003). Isolated case studies of 
small numbers of patients with spinal cord injuries have indicated that RLS and PLM have 
developed following spinal cord insult of various causes. Ten patients with myelopathy had 
associated PLM (Yokota et al., 1991), 3 patients had PLM accompanying a focal thoracic spinal 
cord lesion (Lee et al., 1996), 3 patients following spinal cord lesions diagnosis presented with 
RLS (Hartmann et al., 1999), and RLS developed in one patient after a vascular injury of the 
spinal cord (Tings et al., 2003). The evidence of PLM in patients with spinal cord injury strongly 
supports that PLM are of a spinal cord origin. 
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PLM may have spinal circuitry in common the Babinski reflex and the flexor reflex. Video image 
analysis in the 1980s revealed that PLMS resembled the Babinski sign (Smith, 1985) however 
no objective measure has been done since then to confirm this observation. The importance of 
the similarity between PLM and the Babinski sign is that clinically, the presence of the Babinski 
sign may be indicative of upper motor neuron lesions. Disorders involving upper motor neuron 
lesions, that isolate the spinal cord from supraspinal inhibitory control, are classical examples 
of spinal hyperexcitability (Nielsen et al., 2007). More recently, similarities between the flexor 
reflex and PLM have been demonstrated and the authors suggest that the two may share a common, 
spinal generator (Bara-Jimenez et al., 2000). 
 
Various neurophysiological studies, particularly using the Hoffmann reflex (H-reflex) (discussed 
in detail in section 2.2.3.2.) have been conducted supporting the concept of spinal 
hyperexcitability as the origin of RLS and PLM. The first study showing spinal hyperexcitability 
in RLS patients was performed by Wechsler et al (1986) who found an H/M ratio of 98% in two 
RLS patients and concluded that this was evidence of spinal hyperexcitability. However, the 
other four RLS subjects in their study did not exhibit this increased H/M ratio, these results 
were not compared to control subjects, and statistical analysis was not performed, thus casting 
doubt over these deductions (Wechsler et al., 1986). Subsequently, various researchers testing 
the H-reflex demonstrated impaired H-reflex excitability curves and vibratory inhibition 
depression, indicative of spinal disinhibition (Martinelli et al., 1987; Rijsman et al., 2005) as 
well as decreased inhibition of 1b interneurones (neurones modulating spinal locomotor 
rhythm generators) (Scaglione et al., 2008) which all point towards spinal hyperexcitability in 
RLS and PLM patients.  
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Examination of a different reflex, the nociceptive flexor (withdrawal) reflex, has also shown 
spinal hyperexcitability in RLS and PLM patients. PLM patients’ reflex thresholds were 
decreased during sleep compared to wakefulness which is a reversal of the natural state-
dependent changes in spinal excitability. The patients with PLM also exhibited lower 
thresholds, and thus increased excitability, compared to control subjects during wakefulness 
and during sleep (Bara-Jimenez et al., 2000). Overall these data indicate spinal hyperexcitability 
in PLM patients which is maintained during sleep.  
 
Despite the many arguments supporting the role spinal hyperexcitability may play in RLS and 
PLM, not all the literature shows data supporting the concept of global spinal hyperexcitability. 
Several studies examining the H-reflex showed no differences between RLS and control 
subjects for either H-latency; H-amplitude or H/M ratio (Bucher & Trenkwalder, 1996; Akyol et 
al., 2003; Rijsman et al., 2005; Scaglione et al., 2008). Also, in other neurophysiological tests, 
patients with RLS and PLM exhibited no differences compared to controls in motor and 
sensory nerve conduction, F-wave, blink reflex, flexor reflex responses and mixed nerve silent 
periods (Wechsler et al., 1986; Akyol et al., 2003). These inconsistencies require further 
exploration before the aetiology of central sensitization in RLS and PLM can be confirmed.  
 
A simplified version of the possible descending control pathways that could exist and the 
potential consequences of ‘losing’ the descending pathway are presented in Table 1. The 
descending pathways are either inhibitory or excitatory and will synapse with an inhibitory or 
excitatory neuron. Loss of the descending input to the subsequent neuron will change its 
excitability state. Most of the literature cites that there is disinhibition of inhibitory pathways 
in RLS and PLM patients which would result in hyperexcitability (increased excitability of the 
excitatory neurons). It is possible that loss of a descending inhibitory pathway could also cause 
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long term upregulation of receptors on secondary inhibitory neurons resulting in increased 
inhibitory outputs, which would not present as spinal hyperexcitability. The conflicts in the 
literature regarding the state of spinal excitability could possibly be explained by the 
hypothesis that these are complex neuronal interactions, and that the proposition of global 
spinal hyperexcitability, alone, might be too simplistic as a cause for RLS and PLM. 
 
Table 1: Representation of the descending spinal networks that exist and the possible outputs if there 
was loss of the descending pathway 
Descending pathway Output neuron 
Expected output if there was 
loss of the descending pathway  
Inhibitory Excitatory Increased excitability 
Inhibitory Inhibitory Increased inhibition 
Excitatory Excitatory Decreased excitability 
Excitatory Inhibitory Decreased inhibition 
 
It should be noted that if the various changes in dopamine, iron and spinal cord excitability can 
explain the sensory and motor disturbances in RLS and PLM, the circadian variations which 
form part of the diagnostic criteria would also have to be explained by these same 
mechanisms. 
 
1.3.4. Circadian rhythms of RLS 
    
The higher prevalence of RLS symptoms at night is not only due to patients’ increased 
likelihood of immobility but involves an independent circadian factor (Trenkwalder et al., 
1999a). Both the intensity of sensory RLS symptoms and the number of PLM/hour peak around 
midnight and are at a minimum in the morning as assessed by numerous suggested 
immobilization tests (SIT) throughout the day and night (Trenkwalder et al., 1999a). The 
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number of PLM peak on the falling phase of the 24 hour temperature curve just before the 
minimum and the fewest symptoms occur on the rising phase occurring after the minimum 
(Hening et al., 1999b; Trenkwalder et al., 1999a; Michaud et al., 2004).  
 
The evidence for circadian variations in dopamine concentrations which would account for the 
circadian variation in RLS are however not clear and unequivocal. In healthy subjects, plasma 
and urinary excretion of free dopamine follow a circadian pattern of peaking during the day 
with the trough occurring in the evening (Sowers & Vlachakis, 1984; Kawano et al., 1990). Two 
studies showed no differences in cerebrospinal fluid concentrations of dopamine metabolites 
between RLS and control subjects sampled in the morning (Earley et al., 2001) or the evening 
(Stiasny-Kolster et al., 2004d). However, Earley et al (2006) showed increased concentrations 
of CSF tetrahydrobiopterin (BH4) (BH4 is enzymatic cofactor in the biosynthesis of both 
serotonin and dopamine), HVA: 5HIAA and 3OMD in RLS patients in the morning compared to 
the evening (which were not present in control subjects) indicating greater than normal diurnal 
fluctuations (Earley et al., 2001; Earley et al., 2006). Dopamine, and its metabolite HVA, have 
also been shown to peak in the morning and early afternoon in RLS and Parkinson’s disease 
patients (Poceta et al., 2009).   
 
The diurnal variations of serum iron concentrations in healthy subjects have been well 
documented (Sinniah et al., 1969; Statland et al., 1976; Scales et al., 1988; Dale et al., 2002). 
Blood iron concentrations in the evening decrease to almost half the daytime serum levels in 
healthy individuals (Scales et al., 1988). No consistent diurnal pattern for transferrin and 
ferritin concentrations have been shown (Dale et al., 2002). To my knowledge, the relationship 
between the natural variation of iron, ferritin and transferrin plasma and CSF levels and RLS 
has not been investigated (Baier & Trenkwalder, 2007). 
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Research has also focused on peptide hormone secretions that are either regulated by 
dopamine (prolactin and growth hormone) or that regulate the secretion of dopamine 
(melatonin) (the relationships between dopamine and these hormones are demonstrated in 
Figure 2). Measurements of these hormones provide an indirect measure of the dopaminergic 
system. Dopamine inhibits the release of prolactin and growth hormone. One study found 
normal plasma levels of prolactin and growth hormone in RLS patients. However following L-
dopa administration the authors found greater night time inhibition of prolactin compared to 
controls suggesting that there may be circadian changes to the sensitivity of the postsynaptic 
dopamine receptors (Garcia-Borreguero et al., 2004b). Another study found that although 
prolactin and growth hormone secretions fluctuated throughout the day, there were no 
differences between the 24 hour patterns in RLS patients compared to healthy controls, 
indicating that the hypothalamic-pituitary axis dopamine receptors or those particular 
dopamine pathways may not be involved in RLS (Wetter et al., 2002).  
 
Melatonin exerts an inhibitory effect on the secretion of dopamine and its peak secretion 
coincides with the night time worsening of sensory and motor features of RLS (Michaud et al., 
2004). Melatonin secretion profiles however are no different between RLS patients and 
healthy controls and thus the relationship between increased melatonin secretion and 
increased RLS symptoms remains uncertain (Tribl et al., 2003; Michaud et al., 2004).  
 
While studies focusing on dopamine, iron and related hormones have shown some evidence of 
circadian rhythms, variations in spinal excitability have not been examined in a RLS context. In 
fact, very few RLS neurophysiology studies have taken time of day into account. Rijsman et al 
(2005) examined the H-reflex in the late afternoon, a period when RLS symptoms become 
apparent, and reported impaired H-reflex excitability curves and vibratory inhibition 
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depression (Rijsman et al., 2005). Hyperexcitability of the flexor reflex (lower thresholds and 
greater spatial spread) in PLM patients was shown in the evening (Bara-Jimenez et al., 2000).   
Bucher et al (1996) chose to look at a symptom-free period and no differences were seen in 
the H-reflex parameters.  
 
In summary, although the exact site of the disturbance is not clear, there do appear to be 
disturbances in the dopaminergic pathways and iron metabolism. While both the sensory and 
motor components demonstrate circadian variations the evidence for the mechanisms of these 
underlying circadian variations remains unclear. The lack of information on the sensory and 
motor components of RLS and PLM may be compromised by the limited range of assessment 
tools used previously. 
 
2. THE ASSESSMENT OF RLS AND PLM 
 
The essential components of the RLS diagnostic criteria are that a patient experiencing RLS 
feels an “urge to move” in response to “uncomfortable and unpleasant sensations” in their 
legs. From these agreed diagnostic criteria it is clear that there is a sensory and motor 
component to RLS. The sensory component is characterized by the feeling of abnormal 
sensations in the legs accompanied by an urge to move, and the motor component includes 
sensory relief from physical activity and the involuntary leg movements during wakefulness 
(PLMW) and sleep (PLMS). The objective and subjective assessment of these different aspects 
will be the focus of the sections to follow.  
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2.1. ASSESSMENT OF SENSORY FEATURES  
 
The human somatosensory system involves the relay of sensory information from somatic 
receptors in the body (soma) to intra cerebral nuclei and ultimately to the somatosensory 
cortex of the brain via spinal or cranial nerve pathways. Sensation begins when external or 
internal stimuli stimulate a receptor. The type of receptor that is stimulated varies with the 
sensory modality (e.g. pain stimulates nociceptors). Depending on the type of receptor, the 
ascending spinal pathway occurs via either the dorsal columns (most mechanoreception and 
proprioception) or spinothalamic tract (crude mechanoreception, temperature and pain). 
Tracts ascend the spinal cord to the thalamus where basic processing occurs. Information is 
then relayed to the primary somatosensory cortex for further processing and finally to the 
association cortices to fully characterize the dimensions and location of the sensation. Inputs 
from the limbic system (emotional), cerebellum (primitive response) and the prefrontal cortex 
(rationalization) are also involved in the processing of sensory information.   
 
Dysfunctions of the somatosensory system can occur at numerous points within the complex 
networks and various tools have been developed which allow for the investigation of the 
different sites of dysfunction. This review will focus specifically on assessment techniques of 
sensory function that have been employed or show useful potential in the assessment of the 
qualities and severity of RLS sensations. As these sensations have been described both as non-
painful and painful, aspects of both types of sensations will be explored.  
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2.1.1. Assessing the quality of RLS (non-painful) sensory features  
 
Characterising and classifying the quality of sensations may be helpful in determining the RLS 
diagnosis, the monitoring of RLS severity and in distinguishing RLS from RLS mimics (RLS-like 
disorders) such as leg cramps, positional discomfort and peripheral neuropathy (Hening et al., 
2009). The key to providing differential diagnoses for RLS and conditions that mimic RLS may 
lie in characterising the diagnostic descriptors for each condition in order to distinguish them. 
Also, characterising the RLS descriptors may help to determine if there are different 
pathophysiological mechanisms for different RLS phenotypes. If the mechanisms are different 
for the various RLS phenotypes, then there may be differences in the expression of symptoms. 
Characterising these differences of expression may in turn reflect the underlying differences in 
phenotype. 
 
The study of non-painful sensation experienced by humans, its perception and emotional 
responses have been extensively studied perhaps due to the commercial opportunities which 
arise with the knowledge of how potential customers perceive commercial products. The 
application of such knowledge has been utilized by the lay media to optimize the optimal 
human sensory experience (i.e. flashy visuals for advertising or choosing clothing textures for 
enhancing the tactile experience). Substantial funding is contributed to researching the 
qualities of these non-painful sensations to enhance the users experience and for commercial 
benefits such as perfumes (smell) and food (taste).  In a clinical setting, non-painful sensations 
are perceived to be of less clinical relevance than painful sensations, and therefore have 
attracted less scientific focus. The majority of the sensations experienced by RLS patients are 
non-painful and it is perhaps for the reasons mentioned above that less research has been 
devoted to their interrogation. 
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At present, there are no specific tools to assess the quality of the sensory features of RLS. 
Anecdotal descriptions of RLS such as “tingling”, “painful” and “pins and needles” are cited in 
the literature and up until very recently, there has been no formal assessment or 
comprehensive study assessing the scope of the sensations of RLS. Even the terms included in 
the diagnostic criteria have not been validated in a large scale study. Patients express difficulty 
in describing the unusual sensations of RLS, however the diagnosis of RLS is primarily based on 
the subjective descriptions of sensations. As they stand, the diagnostic criteria are unable to 
exclude conditions that mimic RLS which brings the prevalence statistics into doubt (Hening et 
al., 2009). The perception and communication of sensations are limited by an individual’s 
personal experience of these sensory occurrences, thus making sensory evaluations more 
subjective than is desirable in an assessment methodology. There is a diverse range of possible 
descriptors which lack characterization and classification and yet these terms are used for 
diagnostic purposes.  
 
There is very little data describing the quality of sensations in RLS. One recent study asked RLS 
patients to spontaneously describe their RLS sensations (Karroum et al., 2012). Patients 
described sensory and affective descriptors similar to the anecdotal terms used in the 
literature however very few used ‘unpleasant and uncomfortable’, the terms included in the 
diagnostic criteria. The authors also challenged the idea that there may be a purely motor form 
of RLS as 95% of RLS patients in their study could report sensory descriptors. Further, the 
authors suggest that the most commonly used descriptors by their cohort of patients 
correspond to those used on validated neuropathic pain screening tools (Karroum et al., 2012).  
 
The unusual sensations experienced by patients with RLS were previously described as 
parasethesias and dysesthesias (Hening et al., 1999a). Dysesthesias are defined by the 
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European Federation of Neurological Societies as “abnormal and unpleasant” sensations 
whereas parasethesias are “abnormal but not unpleasant” sensations (Cruccu et al., 2004). The 
RLS diagnostic criteria of “unpleasant and uncomfortable” sensations presumable arise from 
these definitions for dysesthesia and parasethesia. Despite the entrenched use of these terms, 
to date no studies have compared the sensations of dysesthesia and parasethesia with RLS and 
thus it is not certain whether these terms accurately describe RLS. Currently there are no 
descriptive terms for parasethesia and dysesthesia either. Parasethesia and dysesthesia are 
terms usually used to describe spontaneous sensations associated with neuropathic pain. 
Given the similar nature of the spontaneous sensations of RLS, the relationship between RLS 
and pain has also been investigated (and will be discussed in section 2.1.3.1.). 
 
2.1.2. Quantifying the severity of RLS sensations 
 
While relatively little work has been done to qualify the non-pain sensations of RLS, there are 
various approaches to quantify these sensations and their impact on sufferers. There are three 
validated scales assessing the subjective severity of RLS, the International Restless Legs Scale 
(IRLS) (Appendix D) (Walters et al., 2003; Scaglione et al., 2008), the John Hopkins Restless Legs 
Syndrome Severity Scale (JHRLSS) (Allen & Earley, 2001c) and the Visual Analogue Scale (VAS) 
(Tergau et al., 2001; Tribl et al., 2005). 
 
The IRLS is a 10-point scale, designed by the International Restless Legs Syndrome Study 
Group, that reflects on “subjective assessment of the primary [diagnostic] features, intensity 
and frequency of the disorder, associated sleep problems, and probes the impact of symptoms 
on patients mood and daily functioning” (Allen et al., 2003; Walters et al., 2003). Each of the 10 
items in the IRLS is graded from 0-4 based on the perceived severity or frequency. The IRLS is a 
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subjective scale that asks patients to reflect on the severity of their RLS in the past week. The 
IRLS severity score has been used to assess the efficacy of numerous different treatment 
options including: Ropinirole (Trenkwalder et al., 2004a; Walters et al., 2004), Pergolide 
(Trenkwalder et al., 2004b), Cabergoline (Stiasny-Kolster et al., 2004a; Oertel et al., 2006; 
Trenkwalder et al., 2007), Pramipexole (Winkelman et al., 2006) and Rotigotine (Stiasny-Kolster 
et al., 2004b; Trenkwalder et al., 2008). 
 
The JHRLSS, designed at John Hopkins University (as the name would suggest), was the first 
published clinical severity rating scale. It is a far simpler evaluation method than the IRLS, 
comprising of a single question related to the time of RLS symptom commencement. There is a 
choice of never, mild, moderate and severe as subjective intensity ratings based on a 4 point 
scale corresponding to the time of symptom commencement. As symptoms tend to dissipate 
for most patients in the early morning, the time that they begin reflects the duration of time 
that patients endure restless legs. Thus the earlier the symptoms start, the more severe the 
RLS (Allen & Earley, 2001c). The JHRLSS is not used extensively to determine pharmacological 
treatments efficacy however it is used successfully as a clinical assessment tool for the severity 
of RLS. 
 
The Visual Analogue Scale (VAS) is a numeric rating scale commonly used in pain assessment 
studies (further discussed in section 2.1.3). An adaptation of this scale can be used to assess 
the severity of RLS with “not severe” as the one anchor and “most severe” as the other anchor 
(Tergau et al., 2001). The current intensity of RLS discomfort can also be assessed using the 
VAS, with “no discomfort” and “extreme discomfort” as the two anchoring statements 
(Michaud et al., 2002a). The VAS provides an instantaneous assessment of the RLS severity at 
the time of the assessment. VAS score data is entirely dependent on the patient’s 
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interpretation of severity and could reflect anything from the intensity of the actual symptoms 
to the impact of the sensations on mood and function. The VAS has successfully been used to 
assess the improvement of subjective RLS symptoms as a measure of severity, following 
administration of: Apomorphine (Tribl et al., 2005), Piribedil (Evidente, 2001) and Alpha-
Dihydroergocryptine (Tergau et al., 2001). Michaud et al (2002) used the VAS to assess the 
intensity of RLS discomfort at regular intervals and provide an overall quantifiable measure of 
the intensity of sensory discomfort of RLS (Michaud et al., 2002a). 
 
The severity rating scales mentioned above have been used widely and are a critical 
assessment tool for RLS. One of the problems with these scales is that the measures have no 
connection to the quality or severity of the sensations themselves. For example, the IRLS rating 
scale primarily assesses the impact of RLS on the patients sleep and daily functioning but 
provides relatively little information regarding the intensity of the RLS symptoms themselves. 
The presumption is that increasing severity of RLS leads to increased impact. Also, given the 
emerging association between pain and RLS, these rating scales lack specific questions about 
painful symptoms.  
 
2.1.3. Assessing the quality of and quantifying painful sensations  
 
Pain is a component of the sensory profile of many RLS patients and the pain assessment tools 
that have been used in previous RLS studies range from simple pain rating scales through to 
multidimensional qualitative and quantitative approaches.  
 
Direct estimation methods, such as numeric and verbal rating scales are frequently used tools 
in the assessment of pain severity and intensity particularly in settings that require an 
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instantaneous response (Williams et al., 2000). The Visual Analogue Scale (VAS) is one of the 
most commonly used of these methods. This scale is a one dimensional, quantitative 
measurement tool consisting of a single 100mm line that is anchored at either end with the 
extremes of a pain experience (i.e. “no pain” and “worst pain ever experienced”). Patients are 
asked to mark a point between the two anchor points that reflects their present pain. The 
continuous nature of the scale is preferable to numeric or verbal scales which force patients to 
translate their feeling into a numerical value, or choose a single word from a pre-defined list 
(Carlsson, 1983). The two anchors are adaptable, making the VAS a versatile tool for assessing 
various different subjective components. One of the main disadvantages of the VAS is that it is 
a unidimensional tool whereas pain is largely recognised to be multidimensional. 
 
The McGill Pain Questionnaire (MPQ) (Appendix E) was originally developed by Melzack 
(Melzack, 1975) to overcome the problems associated with the previous unidimensional 
description and measurement of pain. There are 20 groups of 78 words on the MPQ and each 
of these is grouped according to the quality of the words and ranked within each group in 
increasing order of intensity. Both the description of the pain (sensory, affective and 
evaluative) and the relative intensity can be defined using the MPQ. A VAS recording the 
present pain is also included in the MPQ. This allows for a multi-dimensional analysis of pain 
compared to the one dimensional assessment provided by simple rating scales. 
 
The qualitative properties and quantitative assessment obtained from the MPQ provide 
different, but related, information regarding pain. Descriptive data is useful in assessing the 
quality and type of pain, whereas the severity of the pain can be calculated either by summing 
the total number of descriptors selected, or by calculating the sum of the ranks of each 
descriptor chosen within the 20 groups. Since its development in 1975, the MPQ has been 
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extensively used in its original and translated formats (Melzack, 1975; Costa et al., 2009) and 
the shortened version has also been validated for situations when time constraints are 
imposed (Melzack, 1987). 
 
The MPQ is particularly useful for assessing clinical pain and determining the therapeutic 
outcomes of pain treatment studies, providing quantitative measurements that can be 
statistically tested (Melzack, 1975). The verbal qualities of pain descriptors on the MPQ can 
also been used to discriminate between different types of pain. Wilkie et al (2001) reported 
that the descriptor choices from the MPQ were different between patients with nociceptive 
and neuropathic pain. Being able to distinguish between different types of pain is important 
when deciding the optimum pain management therapies for each type of pain (Wilkie et al., 
2001). For example, in postoperative pain, a patient complaining of a throbbing pain is 
indicative of pain arising from deep tissue damage whereas a patient, who complains of a 
sharp pain, may be indicating a more superficial source. The qualities of the pain lend 
themselves to indicating their potential location and provide guidance towards the appropriate 
analgesics which would be different for each type of pain (Fortin et al., 1992). 
 
The subjective scales mentioned (VAS and MPQ) can be used to assess clinical pain as is, or can 
be applied to induced pain states, such as those provoked using Quantitative Sensory Testing 
(QST). QST is a non-invasive psychophysical assessment and quantification of the 
somatosensory function of small and large sensory fibres. QST measures the responses to 
mechanical (static and dynamic) and thermal stimuli of varying intensities, normally assessing 
the threshold and tolerance to the stimuli. QST can target specific receptors, peripheral nerve 
fibres or neuroanatomical pathways depending on the testing modality (pain, pressure, touch, 
vibration or temperature) and as such is not restricted to the assessment of pain. Unlike nerve 
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conduction studies which only provide reliable measures of large myelinated sensory afferent 
nerves, QST is a useful tool for assessing sensory function and impairment of large and small, 
myelinated and unmyelinated fibres (Chong & Cros, 2004; Hansson et al., 2007; Bachmann et 
al., 2010). In the context of RLS and studies of patients with PLM, QST has focused specifically 
on testing the function of the pain pathway.  
 
2.1.3.1. Pain assessment tools and RLS 
 
The previously discussed pain assessment tools have been used in RLS and PLM studies in an 
attempt to qualify and quantify the pain sensations of RLS and elucidate the role of the pain 
pathways in RLS and PLM. In particular, the VAS has been used in conjunction with the MPQ 
(Bentley et al., 2007) and as an outcomes measure in QST studies (Edwards et al., 2011).  
 
A small number of RLS studies have included the MPQ as part of their assessment. von Spiczak 
et al (2005) used the pain scores from the affective component of the MPQ as an outcome 
measure to assess the role of opioids in RLS. These pain scores were inversely correlated with 
opioid receptor binding in some areas serving the medial pain system (orbitofrontal cortex and 
anterior cingulate gyrus) (von Spiczak et al., 2005). Subsequently, the MPQ was tested in its 
ability to assess non-painful RLS sensations. The quality and severity of RLS sensations could be 
measured using the MPQ and there was a good correlation between the severity score from 
the IRLS and the severity score calculated from the MPQ. The word choices in RLS patients 
from the MPQ were unique as they were different to the words selected by patients with 
either neuropathic or nociceptive pain (Bentley et al., 2007). Similarly, Karroum et al (2012) 
also found that RLS patients could use the French version of the MPQ to report their sensations 
with a correlation between the IRLS severity score and the MPQ sum of intensity scale values. 
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However, unlike the previous study, Karroum and colleagues report that RLS patients selected 
words that were similar to those in validated neuropathic pain screening tools except that the 
RLS patients also selected words describing cold and numbness which are not neuropathic pain 
terms (Karroum et al., 2012). This discrepancy between the two studies may be due to Bentley 
and colleagues having statistically compared the RLS descriptors with previously reported 
neuropathic pain descriptors whereas Karroum and associates appear to have purely reported 
visually observed similarities. 
 
QST has been successfully implemented as a means to assess the central somatosensory 
processing of pain and temperature related information in RLS patients. RLS patients 
demonstrated central sensitization of nociceptive processing and increased pain sensitivity as 
measured by the increased response to static and dynamic mechanical stimuli (gentle stroking 
stimuli and pin prick) (Stiasny-Kolster et al., 2004c; Bachmann et al., 2010). Psychophysical 
testing (pressure algometer, hot and cold painful stimuli) also revealed lower pain thresholds 
and elevated indices of temporal summation among RLS patients further supporting that there 
is amplified pain processing in RLS patients (Edwards et al., 2011). Assessment of painful and 
non-painful thermal and mechanical perceptions and pain thresholds revealed altered sensory 
modality profiles in primary and secondary RLS patients (Schattschneider et al., 2004; 
Bachmann et al., 2010). QST is a useful tool in the assessment of RLS and PLM and has 
contributed towards the central sensitization theory as the aetiology of these two disorders.  
Whilst pain assessment tools have successfully been used to assess RLS sensory features they 
are limited by the obvious pitfall that not all RLS sensations are painful. The MPQ has been 
used to assess the non-painful sensations of RLS, however it is restricted to pain related words 
and may be unable to assess the full scope of RLS sensations. The non-painful sensations have 
not been successfully assessed and there is no validated measuring instrument for assessment 
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of the non-painful RLS sensations. The combination of sensory and motor features of RLS and 
PLM and the possibility that there is a common aetiology suggests that mechanisms 
responsible for the sensory features may be involved in the motor phenomena of PLM and vice 
versa. Thus assessment of motor features may provide insight into our understanding of both 
disorders. 
 
2.2. ASSESSMENT OF MOTOR FEATURES  
 
Movement has various levels of complexity, from simple reflexes to complex voluntary 
movements, in order of increasing complexity and can be either automatic or volitional 
(Askenasy et al., 1987). The simplest automatic movement, the reflex, can involve a single 
sensory and motor neuron and requires no conscious control for its initiation. Central pattern 
generators and rhythmic movements, also at a spinal level, involve some conscious control and 
may be voluntarily initiated. Complex voluntary movements, as the name implies, are under 
conscious control and involve multiple different features in the nervous system. The complex 
motor pathways initiate in the motor cortex, and via descending spinal motor tracts, synapse 
with the alpha motor neuron, sending action potentials to the neuromuscular junction to cause 
activation of the muscle and subsequent voluntary movement.   
 
The complete range of tools for the assessment of movements is extensive and beyond the 
scope of this literature review, therefore the sections that follow will only describe techniques 
used previously or those that could be used to assess motor features of RLS and PLM. First, 
electrophysiology assessment, which records the electrical signal generated in a muscle which 
has been stimulated by the motorneurone, will be discussed. Following which the thesis will 
review assessment techniques of the actual movement that may be elicited from the electrical 
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activation of the muscle (biomechanics). The uses of both electrophysiology and movement in 
the assessment of the most simple movement, the reflex (as a reflection of spinal cord motor 
function) will then be discussed with particular focus on the excitability state of the spinal cord, 
changes in which have been implicated in the generation of RLS and PLM.  
 
2.2.1. Electrophysiological assessment 
 
Electrophysiology is a means by which researchers are able to record the electrical properties 
of biological cells and tissues. The most common electrophysiological measure used in the 
study of RLS and PLM is electromyography (EMG). The electrical signal (action potentials) 
generated in a muscle in response to motorneurone activity or other electrical events is 
recorded. EMG involves recording electrical activity as a potential difference, between the two 
recording electrodes, representing the neuromuscular activation of the muscle. Recordings are 
made either by surface electrodes placed on the skin over the belly of the muscle or needle 
electrodes inserted into the muscle. Recordings made via surface electrodes are more common 
than the more invasive needle electrode recordings. Needle electrode recordings are however 
more accurate than surface electrode measurements. The most common type of recording 
technique is bipolar, where two electrodes record from the muscle and a third is placed in an 
electrically neutral grounding site (Kamen, 2004).   
 
EMG recordings can be done to reflect the activity of a single muscle or multiple muscles 
simultaneously. Single muscle recordings are useful for determining if a particular muscle is 
involved in an activity and to establishing the frequency and magnitude of that particular 
muscles use. Simultaneous recordings from multiple muscles provide information regarding 
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the relationships of one muscle relative to another. The timing sequence of multiple muscles 
performing a task (for example during walking) can be determined (Kamen, 2004). 
 
The electrical activity recorded by electromyography emanates from action potentials which 
originate in the muscle under the skin. The EMG recording can be affected by many factors and 
as such cannot be used as a direct measure of the number of action potentials. Confounding 
factors that influence EMG readings include: variations in muscle fibre type (where action 
potentials may elicit variations in EMG amplitude with changes in the surface area of a muscle 
fibre/sarcomere); bidirectional movement of action potentials from the neuromuscular 
junction (where surface EMG can vary according to the direction of flow of the action 
potentials); placement and variations in the electrical conductivity of recording and reference 
sites; positioning of the recording electrodes relative to the motor endplate region, skinfold 
thickness and electrode impedance. Other sources of electrical activity (both external and 
other body originated electrical activity e.g. electrocardiogram), may confuse the EMG signal as 
they may not be fully accounted for by using a reference electrode (Kamen & Caldwell, 1996). 
Despite measurement difficulties, recording and analysis of electrical signals involved in 
neuromuscular activation are successfully used to assess motor activity in RLS and PLM 
patients and PLM are defined by activity sequences recorded via surface EMG.  
 
2.2.1.1. Electrophysiology and RLS and PLM 
 
Periodic limb movements, as the name implies, have to do with ‘limb movements’ however 
EMG as part of PSG record the electrical activity of the muscle which is an indirect reflection of 
the actual motion (muscle electrical activity may not necessarily result in movement, see 
below). The EMG recording on the PSG specifically records from a single muscle (most 
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commonly the anterior tibialis in PLM studies) and the EMG activations must fulfil specific 
defining criteria (see section 1.1.2.) to be considered PLM. The severity of the condition is 
calculated based on the number of PLM per hour. As EMG is a recording of muscle activation 
and not the actual leg movement per se, activations can occur without subsequent movement. 
A measurable electrical signal may not cause great enough contraction of the muscle to 
produce a visible movement which may result in overestimation of PLM during PSG 
(Kazenwadel et al., 1995). Alternatively, muscle activation in two opposing muscles (where 
EMG activity is registered), may not result in movement to the opposing nature of agonist and 
antagonist muscles. 
 
The anterior tibialis muscle was originally recommended as the muscle of choice for EMG 
recordings used to detect and quantify PLM, as dorsiflexion of the ankle (a result of anterior 
tibialis muscle contraction) is one of the defining features of PLM (Guilleminault et al., 1975).  
Although the anterior tibialis is the most frequent initiating muscle in the PLM motor 
sequence, other muscles: the gastrocnemius, biceps femoris, rectus femoris and extensor 
digitorum brevis, have also been shown to begin the muscle contraction sequence (Provini et 
al., 2001; de Weerd et al., 2004). The complex muscle recruitment patterns for other muscles 
involved in the PLM sequence are reported to be both inconsistent, even for different 
sequences within the same patients (Provini et al., 2001; Plazzi et al., 2002), as well as regular 
and recognisable, albeit specific to individuals (de Weerd et al., 2004). These results indicate 
that not all PLM follow a fixed, stereotypical pattern as was previously assumed. Despite 
evidence of other muscles being involved in the PLM motor pattern, the anterior tibialis muscle 
is consistently the only muscle recorded to detect and quantify PLM (Provini et al., 2001). By 
only recording from the anterior tibialis muscle there may therefore be a marked 
underestimation of the occurrence of PLM. 
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EMG and movement analysis are complementary, but not necessarily interchangeable, 
measurement tools (see the published papers co-authored by the thesis author in appendices 
H and I for further discussion regarding the relationship between the two measurements). The 
simultaneous use of both electrophysiological and biomechanical methods is particularly useful 
in gait analysis (Vaughn et al., 1999). Assessing the mechanics of the movement generated by 
electrical muscular activity requires a different form of analysis to electrophysiology.   
 
2.2.2. Biomechanical assessment   
 
Movement, in general, can either be translational or rotational. Translational motion (also 
known as linear movement) occurs along a straight or curved line for example the movement 
of the body walking along a path. Rotational or angular motion describes the circular 
movement around a fixed point axis of rotation. Segmental movement of body parts falls into 
the category of rotational motion. For example, in the motion of the lower limb during the 
patellar reflex, the knee joint is the axis of rotation. The measurement of movement describes 
the displacement of one joint relative to another. 
 
Modern biomechanics is a new science originating from the 1970-80s era and the word is 
derived from two concepts, that of life (from the Greek bios) and mechanics. Mechanics is 
defined as “the study of motion of objects, and the related concepts of force and energy” 
(Giancoli, 1998) and therefore biomechanics is essentially the study of the motion (and related 
force and energy) of biological organisms and systems. There are various subdivisions within 
the field of biomechanics, however, and the two areas of relevance to this review are 
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accelerometry and the category of kinematics (a division of dynamic mechanics), defined as 
“the study of time and space factors of motion of a system” (Kreighbaum & Barthels, 1996).    
 
Accelerometry is a low-cost tool for the assessment of human movement in laboratory and 
home environment based studies. Accelerometers are small, lightweight, non-invasive devices 
which can be placed over various joints to measure movement of specific limbs or to provide a 
general whole body activity record. These devices measure limb acceleration, detecting both 
the frequency and intensity of movement, in one axis (uniaxial) or three orthogonal axes 
(triaxial) (Mathie et al., 2004). Activity monitoring (actigraphy) using accelerometry provides a 
less expensive, less intrusive and ambulatory home-based method for assessing movement. 
One of the main advantages of actigraphy is that it is ambulatory and can record continuously 
for extended periods of time. The use of actigraphy, however, also has various limitations. 
Uniaxial accelerometers only provide information about movement in a single plane and 
therefore may not be a true reflection of total movement. The orientation and site of 
placement of the accelerometry device is critical as these relate to the plane of movement and 
determine the type of data recorded (e.g. whole body movement vs. segmental movement). 
Actigraphy cannot specify the type of movement recorded, only that movement has occurred. 
This is particularly important in PLM detection as respiratory related movements may also be 
detected by actigraphy and may be difficult to distinguish from PLM (Hening, 2004a).  
Kinematics provides an objective way to describe the movement of the body or a body part 
within a particular frame of reference. Kinematics can be used to quantify the displacement, 
velocity and acceleration of movement in three dimensions (Kreighbaum & Barthels, 1996; 
Giancoli, 1998). The kinematics tool that I will particularly focus on in this review is video 
kinematic motion analysis.   
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Video kinematic motion analysis involves capturing and tracking motion as visual data, and 
uses three dimensional Euclidian geometry to objectively quantify movement. Non-invasive 
reflective markers are placed on areas that are most useful to capture motion e.g. on the 
joints. The movement of markers is then recorded during the motion to be analysed and the 
data used to back extrapolate the movement of the joint under study. In this way an accurate 
and objective measurement of the motion is obtained. An unavoidable limitation of the non-
invasive kinematics method is that, due to skin movement artefact, the marker movement 
does not always accurately represent the movement of the underlying structures.  
 
2.2.2.1. Biomechanics and RLS and PLM  
 
Actigraphy has been involved in the study of sleep/wake patterns for the last 20 to 30 years 
and more recently specifically used to detect and screen for PLMS and other sleep disorders 
(Sadeh, 2011). In patients with RLS and PLM, actigraphy offers an alternative means to detect 
PLM instead of the gold standard of EMG as part of PSG. The defining criteria for PLM are 
based on muscle activation and do not depend upon actual movements whereas actigraphy 
records actual leg movements. Whether the activation or movement is a more important 
factor in causing the sleep disturbances associated with PLM is yet to be determined.  
 
The use of actigraphy as a screening and even diagnostic tool for PLM has been the subject of 
several studies to determine the reliability and sensitivity of accelerometers in detecting PLM. 
Two review papers concerning the role of actigraphy in sleep studies report on research 
indicating that actigraphy is accurate in detecting PLM but that it is not a suitable replacement 
for the diagnosis of PLM using EMG on PSG (as there may be muscle activations without 
subsequent movement which are not detected by actigraphy) (Sadeh et al., 1995; Ancoli-Israel 
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et al., 2003). A later study also showed that although actigraphy could accurately detect the 
presence of PLM (with greater sensitivity and specificity as PLM index scores increased), Bland 
Altman analysis indicates that actigraphy and EMG as a part of PSG are not interchangeable 
(King et al., 2005). Actigraphy may however be useful in follow up studies, screening for PLM 
and for determining treatment efficacy (Sadeh et al., 1995; Ancoli-Israel et al., 2003). New 
actigraphy devices specifically tailored to detect PLMS are being developed which may assist in 
overcoming some of the problems encountered with using accelerometers for the detection of 
PLM (Sadeh, 2011).  
 
The use of biomechanics (particularly three dimensional motion analysis) for assessment of 
motor function is a fairly novel tool in the investigation of RLS and PLM. One kinematic gait 
analysis study, in conjunction with EMG, has been carried out focusing on RLS patients (Paci et 
al., 2009). The authors found that RLS patients had an abnormal EMG activation of the 
gastrocnemius muscles when walking. Kinematic analysis indicated that the timing of this 
abnormal activation occurred when there should have been relatively less activation of the 
gastrocnemius muscle (relative silence) at that phase of the stance. This same activation was 
not detected in control participants, possibly indicating that RLS patients may have poor 
control of the relative silence. The activation had no detectable effect on gait kinematics but 
the authors suggest that it could be supportive as diagnostic criteria in complicated cases (Paci 
et al., 2009).  
 
The use of biomechanical techniques and electrophysiology in the assessment of reflexes, as a 
reflection of spinal cord motor function, is the focus of the next section.   
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2.2.3. Assessment of spinal reflexes  
 
Spinal reflexes are a combination of sensory and motor pathways. Both excitatory and 
inhibitory descending pathways influence the excitability state of motorneurones and lesions 
of the CNS can result in either hyperactive or hypoactive reflexes. Thus, although spinal 
reflexes are a combination of sensory and motor pathways, changes in the excitability state of 
the spinal cord will influence the motor output and hence assessment of spinal reflexes falls 
under assessment of motor features. 
 
2.2.3.1. General principles of reflexes  
 
Reflexes are relatively stereotypical involuntary muscular contractions initiated in response to 
a sensory stimulus. Reflexes have a sensory and motor component with one or multiple 
synapses that have excitatory and inhibitory possibilities. Although there are many different 
types of reflexes present in the body this review focuses specifically on somatic spinal reflexes.  
 
Abnormal reflex responses potentially indicate underlying changes in the state of the spinal 
cord (Paulus & Schromburg, 2006), thus increased spinal excitability may cause exaggerated 
reflex responses and decreased excitability would present as weak or absent reflexes. Different 
reflexes utilize different neuronal contributions and changes in these reflexes can be used to 
assess alterations of the spinal cord excitability state at various levels. For example, the Achilles 
tendon (ankle) reflex reflects the connections at spinal segments S1 and S2, and the biceps 
reflex traverses spinal segments C5 and C6 (Wang & Cymet, 2005). Muscles inverted at the 
spinal segments L4-S1 levels are activated during PLM (Provini et al., 2001). This thesis will 
particularly focus on spinal reflexes occurring in the lower limbs (spinal segments L2-S2), the 
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site of RLS and PLM. Specific lower limb reflexes included in this thesis to investigate spinal 
excitability are: the Hoffmann reflex (H-reflex) and the patellar reflex. The H-reflex has been 
the most commonly used in RLS and PLM studies and the patellar reflex, a monosynaptic 
reflex, is the most widely used in clinical practise.  
 
Common clinical measurements pertaining to reflexes are the latencies and amplitudes of 
electromyographic readings of muscle activity in the reflex path (Figure 4). Latency, the 
conduction time for the afferent and efferent impulses, defined as the period between the 
time point of stimulation (electrical or mechanical) and the time point of the initial voltage 
deflection in the recording (usually electromyographic) signal. Latency is physiologically 
determined by various components: the conduction speed of the sensory and motor neurons, 
synaptic delay, length of the reflex arc, amount of neurotransmitter released and distribution 
of action potentials (Pomfrett, 2005). Amplitude is a measure of the potential difference (in 
mV) between the positive and negative peak recorded by electromyography (Voerman et al., 
2005) and is an indication of the electrical signal output by the spinal cord - a measure of 
motorneurone activation. The amplitude is largely affected by the quantity of neurotransmitter 
released from the neurons. Neurotransmitter release is influenced by presynaptic inhibition 
and postactivation depression (Misiaszek, 2003). 
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Figure 4: Schematic representation of an electromyographic recording of a biphasic action potential 
recorded during a reflex showing the parameters of amplitude and latency measured to quantify the 
reflex. 
 
 
2.2.3.2. Hoffmann reflex 
 
The H-reflex was first described by Piper in 1912 and later characterised and named after 
Hoffmann in 1918 who described the M- and H- waves (Schieppati, 1987). The H-reflex is 
elicited by percutaneous electrical stimulation of a mixed (both sensory and motor axons) 
peripheral nerve and recorded by bipolar surface electrodes placed over the relevant muscle 
that is being innervated by the stimulated nerve (Zehr, 2002). The H-reflex is mainly used in the 
detection of neuropathies and radiculopathies where the H-wave is either delayed or absent. 
The H-reflex can be tested on numerous different muscles, particularly those in the 
extremities, thereby varying the spinal segments being tested. Most common, and of relevance 
to this review, is examination of the lower limbs. H-reflexes performed on the peroneal and 
tibial nerves measure functioning of spinal segments L5, S1 and S2.  
 
The H-reflex is often referred to as a monosynaptic reflex. However, despite the largely 
monosynaptic circuitry, conflicting literature indicates that there are also oligosynaptic and 
polysynaptic contributions to the H-reflex (Misiaszek, 2003). In part, the percutaneous 
electrical stimulation method used to evoke the H-reflex also has the potential to activate 
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surrounding neurons (including group 1b afferents innervating Golgi tendon organs and 
cutaneous fibres) which provide other neural input (Misiaszek, 2003).  
 
 
Figure 5: Schematic representation of the pathway involved in the H-reflex and the associated 
electromyographic tracing of the M-wave and the H-reflex. The question mark indicates possible 
polysynaptic neuronal contributions. α represents the alpha motor neuron. 
 
 
The mixed nature of the nerve prevents external electrical stimulation from exciting either just 
the sensory or just the motor nerve therefore both are depolarized during the H-reflex 
procedure (Figure 5). The stimulation point of the H-reflex bypasses the muscle spindle by 
directly activating the sensory afferent and action potentials are propagated in both directions 
in the nerve: towards the spinal cord and towards the muscle. Sensory afferent information is 
transmitted via type 1a nerve fibres to the spinal cord where these fibres synapse directly onto 
alpha motor neurons. The resulting reflex response is termed the H-reflex (or H-wave). The 
action potentials travelling in the opposite direction (towards the muscle) are a result of direct 
 
 
56 
 
stimulation of axons of the alpha motorneurones and cause direct contraction of the muscle. 
This direct motor response is termed the M-wave (M standing for muscle) and has a shorter 
latency than the H-wave because of the close proximity of the stimulation site to the muscle 
(Zehr, 2002).  
 
The procedure of inducing the H-reflex involves stimulating the mixed nerve with gradually 
increasing intensities. The larger diameter of the sensory 1a-afferents allows them to 
depolarize at lower stimulation intensities than the α-motorneurones thus the threshold of the 
H-wave is lower than that of the M-wave. Therefore, as the stimulation intensity is increased 
from sub-threshold, the H-wave will appear without an M-wave but, at greater stimulation 
intensities, the smaller diameter α-motorneurones are recruited and the M-wave becomes 
apparent (Zehr, 2002). Propagation of action potentials in the α-motorneurones occurs in both 
directions, resulting in antidromic ‘traffic’ in the axon of the motorneurone going towards the 
spinal cord as well as orthodromic traffic towards the peripheral muscle. As the action 
potential ‘traffic’ towards the spinal cord increases it prevents the signal from the spinal cord 
from reaching the muscle and recording electrodes. The H-wave therefore decreases with 
increasing stimulation intensity until it is eventually blocked and only the M-wave is visible. At 
maximal stimulation intensity the M-wave should be a measure of activation of the entire 
motorneuronal pool. The relationship between the amplitudes of the H- and M-waves 
measured at increasing stimulus intensities is expressed as the H/M ratio and is indicative of 
the excitability of the motor neurons. A recruitment curve is a representation of the 
amplitudes of the H- and M-wave plotted against stimuli intensity and depicts the relationship 
between the two as the electrical stimulus intensity is increased (Voerman et al., 2005).  
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The normal and abnormal values for the soleus H-reflex measures of latency, H/M ratio and 
amplitude were extensively reviewed by Voerman et al (2005). The mean H-wave latency in 
healthy subjects was from 28.2 - 31.2ms, amplitude was between 1.44 and 10.05mV and H/M 
ratio from 0.06 – 0.66. In cases of upper motor neuron lesions the mean range of latency was 
between 28.6 – 32.2ms, amplitude between 4.9 to 7.21mV and H/M ratio from 0.32 – 0.9 
(Voerman et al., 2005). Clearly, for all three measures there is a distinct overlap between 
normal and so called abnormal values, however given these results were taken from a range of 
studies, different methodologies should be taken into consideration as these could account for 
the differences observed. Despite the range in potential values the H-reflex is a widely used 
experimental neurophysiological tool and can be useful in determining changes in the spinal 
cord if methodologies are consistent. Conditioning stimulation, where electrical or vibratory 
stimulation is applied elsewhere in the body (i.e. the Achilles tendon), leads to facilitation or 
suppression of the H-reflex (Misiaszek, 2003) and is often used to standardise the H-reflex 
response. 
 
Due to the different methodologies and related issues of stimulating and measuring the H-
reflex, an alternative reflex, reflecting similar neuronal circuitry, may be useful in assessing 
spinal excitability. The patellar reflex, although monosynaptic, is often considered as the 
mechanical counterpart of the H-reflex. 
 
2.2.3.3. Patellar reflex 
 
The patellar or knee jerk reflex is a deep tendon, stretch reflex initiated by a hammer strike on 
the patellar tendon causing extension of the lower leg (Wang & Cymet, 2005). Muscle spindles 
in the quadriceps muscle detect the stretch of the muscle and this sensory information is 
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transmitted via type 1a afferent nerve fibres to the dorsal root ganglia. In the spinal cord 1a 
afferent fibres synapse directly onto alpha motor neurons that innervate the same muscle, the 
quadriceps, from which the sensory stimulation arose (Figure 6). The simple reflex arc initiated 
by the muscle stretch activates the quadriceps muscle to contract causing extension of the 
lower leg. Interneuron in the spinal cord activated by incoming sensory information inhibit 
contraction of the antagonist group of hamstring muscles, and relay information regarding the 
reflex to higher brain regions involved in movement and sensation.  
 
Figure 6: Schematic representation of the monosynaptic patellar reflex arc. α represents the alpha 
motor neuron. 
 
The patellar reflex is commonly used in clinical practice as an indicator of the state of spinal 
excitability, and is the only true monosynaptic reflex. The importance of the monosynaptic 
reflex is that the simple reflex arc is an accurate and independent reflection of spinal 
excitability. The patellar reflex arc exclusively traverses spinal segments L2, L3 and L4 (Wang & 
Cymet, 2005) therefore demonstrating the excitability of this particular region and testing the 
functionality of the femoral nerve. 
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Measuring the amplitude of the reflex has only been done at a clinical level. Accordingly, the 
Mayo Clinic Scale (Manschot et al., 1998) and the National Institute of Neurological Disorders 
and Strokes (NINDS) myotatic reflex scale (Hallett, 1993) were developed to evaluate muscle 
reflexes (Table 2).  
 
Table 2: The Mayo Clinic Scale and the National Institute of Neurological Disorders and Strokes 
(NINDS) myotatic reflex scale for evaluating muscle reflex responses 
Mayo Clinic Scale 
(Manschot et al., 1998) 
NINDS myotatic reflex scale 
(Hallett, 1993) 
-4 Absent 0 Absent reflex 
-3 Just elicitable 1 
Small, less than normal trace response or 
requires reinforcement 
-2 Low 2 Normal (lower half of range) 
-1 Moderately low 3 Normal (upper half of range) 
0 Normal 4 Enhanced reflex often including clonus 
1 Brisk   
2 Very brisk   
3 Exhaustible clonus   
4 Continuous clonus   
 
Clearly, both the NINDS and Mayo Clinic scales are dependent on observer interpretation and 
are therefore highly subjective and require the experience of clinical judgement. The two 
extremes of both scales are more easily identifiable but points in between are less 
distinguishable. This is acceptable in clinical practise, but for reporting quantified results in 
research papers a more precise measure is required. The relationship between the NINDS or 
Mayo Clinic scale and EMG measurements of reflex response is reported by some as fair (Stam 
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& van Crevel, 1990) but others conclude that there is great variability (Zhang et al., 2000). In 
research that I have co-authored, we found strong correlations between both the subjective 
NINDs and Mayo Clinic scale and objective biomechanical and EMG measures of the patellar 
reflex (Dafkin et al., 2012, Appendix I).  
 
An objective measure of the patellar reflex would eliminate potential confounders based on 
clinicians’ judgment. Mamizuka et al (2007) designed a more objective measure by attaching a 
tri-axial accelerometer to the ankle and recording the time delay (29.6 ± 6.0ms) and 
acceleration time (150.8 ± 19.5ms) of the reflex. The authors included a comparison between 
healthy and spastic subjects providing normal and hyperexcitable spinal cord data, but the 
standard deviation for each group was greater than the differences between the groups 
(Mamizuka et al., 2007). We found, in recent research that I have co-authored, that there is 
strong positive correlation between kinematically measured patellar reflex variables 
(particularly change in knee angle) and EMG measures of reflex amplitude (Dafkin et al., 2012, 
Appendix H). 
 
The range of patellar reflex latencies and amplitudes in normal healthy subjects on EMG have 
been investigated by various researchers (Stam & Tan, 1987; Frijns et al., 1997). 
Electromyographic recordings of the right rectus femoris muscle showed the mean patellar 
latency to be 21 ± 1.5 ms at rest and 20.8 ± 1.5ms when facilitated by the Jendrassik 
manoeuvre. The mean patellar EMG amplitude was 1.8 ± 1.2 mV at rest and 2.4 ± 1.4 mV when 
facilitated by the Jendrassik manoeuvre (Frijns et al., 1997). Similar patellar reflex latencies of 
19.9 ± 1.7ms (Pereon et al., 2004), and similar quadriceps amplitude of 1.4 ± 0.2mV were 
reported by other studies (Stam & Tan, 1987). The reported mean latencies differ slightly 
between studies and even within studies when testing different patellar hammer models 
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(Frijns et al., 1997). These differences are attributed to variations in the way latency is 
measured. Reflex latency is measured (in ms) from the point of tendon stimulation referred to 
as the ‘starting point’. The ‘starting point’ may vary depending on the delay between striking 
the tendon and the actual start of the timing measurement which is reported to be different 
for different patellar hammer models. Other factors that influence the latency are the striking 
force of the patellar hammer and underlying muscle tone (Pereon et al., 2004). Despite these 
small variations, using the reflex latency appears to be more reliable than reporting reflex 
amplitude. The EMG amplitude of the patellar reflex was reported to differ despite a 
consistent ‘striking’ which produced a similar reflex latency each time (repeated 12 times) 
(Frijns et al., 1997). The reflex amplitude is often used diagnostically however given its 
potential for wide variability, it should be used cautiously.  
 
2.2.3.4. Assessment of spinal reflexes in RLS and PLM 
 
The spinal cord is implicated in the production of RLS and PLM sensorimotor symptoms as it is 
the primary input of sensory afferents and final output stage of motorneurones (Paulus & 
Schromburg, 2006). The spontaneous sensations and movements of RLS and PLM suggest an 
increased excitability of the neurones in the spinal cord. The evidence for this is limited and is 
dependent on studies undertaken using reflexes.  
 
The majority of research examining the state of spinal excitability in RLS and PLM patients has 
involved the H-reflex. Evidence supporting a state of spinal hyperexcitability that has been 
obtained previously includes: an increased H/M ratio in RLS patients (Wechsler et al., 1986), 
impaired H-reflex excitability curves (Martinelli et al., 1987; Rijsman et al., 2005); depressed 
vibratory inhibition (Achilles tendon vibration) (Rijsman et al., 2005) and decreased 1b 
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interneuron inhibition compared to healthy controls (Scaglione et al., 2008). However, not all 
the H-reflex data supports the concept of global spinal hyperexcitability in RLS and PLM 
patients. Several studies examining the H-reflex showed no differences between RLS and 
control subjects for either H-latency; H-amplitude or H/M ratio (Bucher & Trenkwalder, 1996; 
Akyol et al., 2003; Rijsman et al., 2005; Scaglione et al., 2008). The obvious difference between 
the H-reflex data for and against spinal hyperexcitability in RLS and PLM patients is the 
different measurement parameters. The majority of the evidence indicating spinal 
hyperexcitability in RLS and PLM patients was detected under the influence of conditioning 
stimulation. 
 
Another reflex that has been tested in RLS and PLM patients is the nociceptive flexor reflex, 
whose motor sequence has been noted to be similar to PLM. One study demonstrated state 
dependent lower threshold and greater spatial spread of the reflex in PLM patients which was 
proposed to indicate spinal hyperexcitability (Bara-Jimenez et al., 2000). Another study 
however, showed that the flexor reflex amplitudes were normal for RLS and PLM patients 
(although these were not compared to a control group included in the study) (Wechsler et al., 
1986).  
 
No other spinal reflexes have been tested in RLS and PLM patients. Brainstem reflexes have 
been tested but are cranial nerve reflexes and therefore do not fall under the field of spinal 
reflexes. Therefore, reflex testing primarily using the H-reflex has been inconclusive. Focusing 
research on other reflex pathways, for example the patellar reflex, may be helpful in 
elucidating the aetiology of RLS and PLM and particularly spinal hyperexcitability. 
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Given the circadian component of the RLS diagnostic criteria, it should follow that any changes 
in spinal excitability in RLS patients should exhibit circadian variations. For example, it would 
be expected that there would be a state of spinal hyperexcitability in the evening when RLS 
symptoms are present and that there would be decreased excitability in the morning when 
symptoms dissipate. Surprisingly, this hypothesis has not been tested in RLS patients.  
 
In normal subjects, the literature regarding circadian variations of the natural state of spinal 
excitability, as tested by the various different reflexes, is conflicting. The H-reflex and the 
stretch reflex have both been shown to have increased evening amplitudes compared to the 
morning (Dowman & Wolpaw, 1989; Lagerquist et al., 2006) but in other hands also to 
demonstrate no circadian variations (Castaingst et al., 2004; Guette et al., 2005; Lagerquist et 
al., 2006). The evidence of naturally increased spinal excitability in the evening would support 
the hypothesis that spinal hyperexcitability in the evening is responsible for the symptoms in 
RLS patients.  
 
2.3. MIXED SENSORY AND MOTOR ASSESSMENT   
 
Whilst the sensory and motor features of RLS and PLM can be assessed separately, as has been 
the focus of this review to this point, there has been relatively little focus on the assessment of 
both features in conjunction and their relationship to each other. Given the high co-morbidity 
between RLS and PLM, and the likely possibility that they have similar origins, it would be 
useful to assess the sensory and motor features simultaneously and the Suggested 
Immobilization Test fulfils this requirement.   
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2.3.1. Immobilization tests 
 
The Suggested Immobilization Test (SIT) was developed by Montplaisir et al (1998) as an 
objective diagnostic criterion to quantify motor restlessness (PLMW) associated with RLS. The 
test exploits the diagnostic criterion that RLS symptoms are most often present during periods 
of rest. In the SIT test protocol, subjects are required to sit up in bed at a 45° angle with their 
legs outstretched and remain vigilant for the full 60 minutes of the test. Bilateral EMGs of the 
anterior tibialis muscles are recorded and patients are asked to limit their voluntary 
movements as much as possible during the suggested immobilization (Montplaisir et al., 1998). 
The EMG recordings are scored according to criteria established by Michaud (Michaud et al., 
2001) and are presented as the PLMW index (the number of leg movements per hour of 
immobility). The immobility provokes RLS symptoms as well as involuntary movements making 
the SIT an ideal test to assess simultaneous presentation of the sensory and motor features of 
RLS and the relationship between them. Sensory symptoms can be assessed in conjunction 
with the motor component by asking subjects to complete a discomfort visual analogue scale 
(VAS) every 5 minutes for the hour of the test (Michaud et al., 1999). The mean discomfort 
score represents the average value of all the 5 minute measures (Michaud et al., 2002b).  
 
The Forced Immobilization Test (FIT), also developed by Montplaisir and colleagues, is similar 
to the SIT except that the patient’s legs are strapped into a restrictive device to physically 
prevent voluntary movements (Montplaisir et al., 1998). Surprisingly, the results observed for 
the FIT showed fewer leg movements than the SIT despite a greater degree of immobility. The 
authors speculate that the nature of the FIT immobilization would not allow relief from the 
discomfort and thus there were fewer leg movements, possibly suggesting that there is an 
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element of conscious input into PLM. Following the validation of the SIT, it was favoured for 
further studies and the FIT is rarely utilised now. 
 
The SIT has been modified in various studies to be performed over different lengths of time. 
Initially the test was performed for 30 minutes (Brodeur et al., 1988), but the standard 
protocol has become 1 hour (Michaud et al., 2002a; Michaud et al., 2002b; Garcia-Borreguero 
et al., 2004a; Haba-Rubio & Sforza, 2006; Aksu et al., 2007). Several studies have shown that in 
RLS patients, RLS discomfort and number of PLMW increase patients after 30 minutes of the 
SIT (Michaud et al., 2002a; Aksu et al., 2007), justifying the argument that the SIT should be 
carried out for over 30 minutes.  
 
The SIT has a diverse range of applications. It has been used diagnostically to discriminate 
between RLS patients and control subjects (Montplaisir et al., 1997; Michaud et al., 2002a; 
Michaud et al., 2002b); to assess the relationship between sensory and motor features of RLS 
(Pelletier et al., 1992; Michaud et al., 2002a; Michaud et al., 2002b; Birinyi et al., 2005; Aksu et 
al., 2007); to determine the effects of rest duration over time (Michaud et al., 2002a; Birinyi et 
al., 2005); as a measure of severity of RLS (Garcia-Borreguero et al., 2004a; Haba-Rubio & 
Sforza, 2006; Aksu et al., 2007); to examine the association between leg movements during 
wakefulness and sleep (Garcia-Borreguero et al., 2004a; Michaud et al., 2002a; Michaud et al., 
2002b); to assess the success of pharmacological treatments (Brodeur et al., 1988; Tribl et al., 
2005; Vetrugno et al., 2007b); and to assess circadian variations of symptoms (Trenkwalder et 
al., 1999a). 
 
As part of the proposition that the SIT is an objective, diagnostic criterion for RLS it requires a 
feature that allows it to discriminate RLS patients from control participants and the SIT PLMW 
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index has been proposed for such diagnostic purposes (Montplaisir et al., 1997; Michaud et al., 
2002a; Michaud et al., 2002b). The exact number of PLMW however, required for 
distinguishing between RLS and control subjects, varies between studies.  
 
Montplaisir et al (1998) originally demonstrated that a SIT PLMW index of greater than 40 was 
able to differentiate RLS patients from control participants (Montplaisir et al., 1998). However, 
both Michaud et al (2002) and Haba-Rubio and Sforza (2006) proposed that a much lower 
PLMW index of 12 successfully divided RLS and control participants. Cut-off points for these 
studies were statistically calculated based on receiver-operator curve analysis and defined as 
“the value that most minimized the misclassification of patients and controls” (Montplaisir et 
al., 1998; Michaud et al., 2002b). The discrepancy shown between the two cut off points may 
be because of underlying differences in the presentation and severity of RLS. Also, the PLMW 
index is a measure of PLM, a feature which not all RLS patients present with (Allen & Earley, 
2001b).   
 
Interestingly, the cut off criteria suggested above do not always hold. Using the proposed cut 
offs, the participants in the study by Garcia-Borreguero et al (2004) would have been excluded 
as RLS patients based on their mean PLMW index (11.8 ± 5.4), however these were all 
confirmed RLS patients (Garcia-Borreguero et al., 2004a). In another study the control 
participants had a morning PLMW index of 33.6 ± 62.2 and an evening PLMW index of 15.5 ± 
22.5, both greater than the PLMW index of 12 as a cut off. Also, the standard deviation of the 
morning value implies that some of the control participants would clearly have PLMW index 
scores of greater than 40. However these control participants did not fulfil any of the RLS 
essential diagnostic criteria (Gamaldo et al., 2009). Healthy control participants can exhibit 
PLM (during wakefulness and sleep) without underlying pathology (Ancoli-Israel et al., 1985; 
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Dickel & Mosko, 1990) (as has been previously discussed in section 1.1.2). Although a good 
index of motor restlessness, the SIT is not yet reliable enough to separate true RLS patients 
from controls and some other features may be needed to improve the diagnostic accuracy of 
this technique.  
 
One such additional feature of the SIT test is exploration of discomfort exacerbation with rest. 
Accordingly, Michaud et al (2002) showed that the SIT mean discomfort score was better able 
to discriminate RLS patients from controls than the PLMW index (Michaud et al., 2002b). The 
SIT mean discomfort score showed higher sensitivity for diagnosing RLS than the PLMW index 
(82 ± 8% vs. 62 ± 10%) and both had the same specificity (84 ± 10%). The SIT mean discomfort 
score was able to correctly classify 82.7% of patients and controls whereas the PLMW index 
only had an accuracy of 69.3%. Further studies are required to confirm the use of the SIT 
discomfort score as a diagnostic tool for RLS, however it shows promise and greater reliability 
than the PLMW index.  
 
Another way to explore the connection between the sensory and motor features is to look at 
their relationship to each other during the SIT. The immobility of the SIT invokes both the 
sensory and motor features of RLS. Given the high co-morbidity between RLS and PLM it would 
seem likely that there is a relationship between the sensory and motor features however the 
related literature is inconsistent. Whether the sensory drives the motor or the other way 
around or they are independent features is debatable. The PLMW index plateaus after 35 
minutes of the SIT, but the discomfort levels continue to increase throughout the test 
(Michaud et al., 2002a). Whether the plateau observed is as a result of the legs being unable to 
produce more PLMW (“ceiling effect”), or that there is actually a dissociation between the 
sensations and movements at this point, requires further exploration (Birinyi et al., 2005). This 
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trend is apparent for RLS patients who have high numbers of PLMW, however those with fewer 
PLMW show a simultaneous increase in both PLMW and discomfort (Birinyi et al., 2005). 
 
Some studies have focused on the temporal relationship of the sensory features in relation to 
the movements during the SIT and the FIT. Weak positive correlations between discomfort and 
the PLM index have been shown in some studies (Michaud et al., 2002b; Aksu et al., 2007) and 
no relationship was shown in a further study (Michaud et al., 2002a). Nearly half of all the 
PLMW occur independently of associated sensations (Pelletier et al., 1992), and almost half of 
the sensations are not associated with movements (Birinyi et al., 2005). Nearly 75% of the 
sensations occur after the movement with the remainder occurring before the PLMW (Pelletier 
et al., 1992; Birinyi et al., 2005). Both concluded that there was a dissociation between the 
sensory and motor features and thus it could not be determined whether the sensations drive 
movements or vice versa.  
 
The relationship between the severity of RLS and its sensory and motor features also appears 
to be undefined. The SIT PLMW index correlated with the IRLS severity score in one study 
(Garcia-Borreguero et al., 2004a), however this relationship was not demonstrated in other 
studies (Haba-Rubio & Sforza, 2006; Aksu et al., 2007). The validity of the finding that severity 
correlated with the PLMW index is not obvious. Looking at the distribution of the PLMW in the 
study by Garcia-Borreguero and colleagues, they are clearly left skewed, with a possible outlier 
at the extreme high end of PLMW possibly forcing the correlation (Garcia-Borreguero et al., 
2004a). The same analysis of the studies that indicated no relationship between the SIT PLMW 
index with the IRLS severity score could not be performed because these studies did not 
include the relevant data. 
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Only one study has assessed the relationship between RLS severity and sensory discomfort and 
found a positive correlation between the two (Aksu et al., 2007). The relationship between the 
severity and discomfort is not surprising as the mean discomfort score measured using the VAS 
scale in the SIT is both a reflection of the discomfort and the current intensity and severity of 
RLS. The current, commonly used, IRLS severity scale does not reflect the actual current 
intensity of the symptoms which is the focus of the measurements made with the SIT, so the 
two may be measuring different factors that both influence the severity of RLS. Further 
research is required to ascertain the usefulness of the SIT as a measurement tool to assess the 
severity of RLS. 
 
The SIT has been proposed as a more convenient and time efficient method of assessing PLM 
compared to the overnight PSG recording of PLMS and PLMW; however its use requires further 
validation. Only a few studies have been conducted focusing on the relationships between the 
SIT PLMW and the PSG PLMS and PSG PLMW however the findings from these methods are not 
consistent. SIT PLMW index was shown to marginally correlate with PSG PLMS and PLMW 
(Garcia-Borreguero et al., 2004a), and also to have no relationship with PSG PLMS and PLMW 
(Michaud et al., 2002a; Michaud et al., 2002b). Clearly, these relationships require further 
exploration before the SIT can be used in place of PSG screening of PLM. 
 
The SIT has also been used to assess the success of treatment interventions and objective 
evaluation of augmentation. The original paper describing the SIT assessed the efficacy of L-
Dopa in treating RLS and showed a reduction in the number of PLM the evening after the 
administration of the L-Dopa (Brodeur et al., 1988). Apomorphine, a combined opioidergic and 
dopaminergic agonist, administered to RLS patients resulted in a rapid and marked 
improvement in sensory and motor features as measured by the VAS and PLMW index from 
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the SIT (Tribl et al., 2005). A case study reported by Vetrugno et al (2007) used the SIT to 
evaluate the augmentation of symptoms exacerbated by Tramadol, and then assessed the 
patient again with the SIT to show an improvement of symptoms following a change in 
treatment (Vetrugno et al., 2007b). 
 
The inconsistent relationships between SIT measurements (PLMW and sensory features), RLS 
severity and PLMS may all reflect that RLS is a heterogeneous disorder and underlying 
differences in population samples may account for the major differences noted. Therefore 
future studies may need to be more selective in subject selection to create a more 
homogenous sample before we can obtain consistent results. 
 
In conclusion, numerous techniques have been employed to assess both the sensory and 
motor features of RLS and PLM and our knowledge of these disorders has been advanced by 
the assessment techniques that are available. However, there are still gaps in our 
understanding of the aetiology, perception and clinical assessment of RLS and PLM and further 
research using new techniques is still required to fully understand these disorders and provide 
effective treatment for them. 
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3. RATIONALE FOR THE PRESENT STUDIES  
 
RLS and PLM have distinct sensory and motor features and presumably share a common 
aetiology given their high co-morbidity. Despite knowledge that dopamine agonists, and to a 
lesser extent opioids, effectively treat the symptoms of RLS and PLM, the aetiology of both is 
unclear. Extensive research has been conducted on these two disorders, particularly in recent 
years, however there is still a lack of reliable assessment tools available to investigate them. 
 
Currently, the diagnosis of RLS is based primarily on a patient’s description of their symptoms. 
This is a subjective measure and patients themselves indicate difficulty in describing their 
sensations. The terms which patients use to describe their sensations have not been 
characterised nor have the sensory descriptions patients use been compared to the descriptors 
included in the diagnostic criteria. Effective descriptions about RLS sensations may contribute 
to more accurate diagnosis, which may, in turn, improve our understanding of their aetiology. 
Therefore my first study focused on the descriptors used by RLS patients to describe their 
sensations. English speaking South African participants fulfilling all four of the RLS diagnostic 
criteria completed a semi structured interview, comprising the following: a spontaneous 
description of their sensations, completing the IRLS and MPQ, followed by the selection of 
terms relevant to their sensations from a literature derived list of RLS words and phrases. The 
most frequently offered and selected descriptors were determined and compared to the terms 
used in the diagnostic criteria.  
 
The first study (above) set the foundations for the second study, which focused on whether the 
presence of painful RLS sensations influenced the choice of descriptors chosen. A subgroup of 
RLS patients experience painful RLS (up to 80% of patients), but whether these patients have 
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any underlying pathological difference is unknown. The same set of participants included in 
study one were categorised based on their self-reported presence or absence of painful RLS 
symptoms, confirmed by differences in their MPQ scores. The word choices between the 
painful and non-painful groups were compared to determine if pain influenced how a patient 
perceived and reported their sensations. Defining the word choices of the different 
phenotypes, may help improve the diagnosis of RLS and assist in the elucidation of RLS 
aetiology.  
 
There are clear sensory and motor components to the terms that patients use to describe their 
RLS sensations i.e. “feels like bubbles in my veins” (purely sensory), whereas “it’s just an urge 
to move” relates to movement. For my third study, the focus of the thesis shifted from 
assessment of the sensory features to assessing the motor component of RLS. In this third 
study I specifically focused on the motor output of the spinal cord.  
 
Evidence in the literature to date suggests that these disorders are caused by functional 
abnormalities of the central nervous system and, of particular interest to my third study, 
hyperexcitability of the spinal cord. Due to the contradictory data from currently used 
techniques I wanted to examine the excitability state of the spinal cord of RLS patients using a 
new technique. And, in accordance with the diagnostic criteria stating that symptoms should 
worsen in the evening, I also wanted to investigate whether the state of spinal excitability in 
RLS patients differed between the asymptomatic morning and symptomatic evening periods. 
Considering the idea that PLM and RLS are possibly the product of state dependent 
disinhibition of inhibitory pathways (Quatrale et al. 2003) and that circadian influences appear 
to play a determining role in their expression (Hening et al. 1999b), it is surprising that time 
factors have not been taken into account in previous studies of reflex activity in these patients. 
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I used two different reflexes to assess differences related to different spinal locations and 
stimuli. The two reflexes (patellar and H-reflex) share largely similar neuronal circuitry but 
traverse the spinal cord at different levels and are stimulated via different methods. The 
patellar reflex was chosen due to its monosynaptic nature (thus limiting other neuronal 
influences) and the H-reflex was used as the electrical counterpart of the patellar reflex 
(despite conflicting literature about oligosynaptic inputs) which has been used in previous RLS 
studies. Using kinematics in conjunction with electrophysiology, I hoped to accurately 
determine if in fact there is a state of hyperreflexia and spinal hyperexcitability in patients with 
RLS, which would present during the evening period when symptoms peak. 
 
The purpose of using both kinematics and electrophysiology to assess spinal reflexes was to 
simultaneously measure the electrical muscle activation and the consequent movement. 
Clinical assessment uses either EMG (for muscle activation) or visual rating scales of reflexes 
(for movement) (e.g. NINDS) however the relationship between these is yet to be quantified. It 
would be a natural assumption that the one would relate to the other but, to my knowledge, 
this has not been assessed for the patellar reflex and particularly not in the unusual case of 
RLS. Subsequently, this information in this group of patients should be particularly important in 
assessing the use of actigraphy as a screening/recording device for PLM. As a development 
from this research, a subsequent project has assessed the relationship between electrical 
muscle activation and the movement during the patellar reflex in healthy people. Two 
publications co-authored during the period of PhD candidature are attached as Appendix H and 
Appendix I. 
 
Finally, because RLS is described as a sensorimotor disorder it is essential to assess both the 
sensory and motor features together, but very little of this interactive research has been done. 
 
 
74 
 
The Suggested Immobilization Test (SIT) provokes RLS discomfort and motor restlessness 
thereby facilitating the simultaneous assessment of both these features. Despite many RLS 
patients reporting painful sensations, these have not been previously assessed during the SIT. 
 
In my fourth study the relationship between the discomfort, pain and motor activity during the 
SIT was assessed in RLS patients. Continuing from the idea in study two that painful RLS may be 
a different presentation of the disorder, I specifically asked patients to distinguish between RLS 
pain and RLS discomfort on separate Visual Analog Scales for each sensation. Concurrent 
bilateral EMGs of the tibialis anterior (the most commonly activated muscle during PLMs) were 
also recorded. 
 
Thus the four studies look at new types of assessment for the sensations alone, the motor 
activity alone as well as the combination of sensory and motor function during the SIT.  
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4. AIMS OF THE RESEARCH 
 
Overall the aim of the thesis is to investigate different aspects and assessments of the sensory 
and motor features of RLS and PLM, subjectively and objectively. The specific objectives for 
each of the studies are:  
 
1. To describe and characterize the sensations of RLS symptoms in an English speaking 
South African population. 
2. To examine how the presence of pain influenced the descriptor choices used by RLS 
patients.  
3. To objectively quantify the H-reflex and patellar reflex in RLS patients compared to 
control participants at two different times of the day. 
4. To explore the relationship between sensory symptoms, both pain and discomfort, and 
motor activity during the Suggested Immobilization Test in patients with RLS. 
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CHAPTER 2 
 
 
Paper one: Kerr S, McKinon W and Bentley A. 
Descriptors of Restless Legs Syndrome sensations. 
Sleep Medicine 2012; 13(4): 409-413. 
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CHAPTER 3 
 
 
Paper two: Kerr S, McKinon W and Bentley A. 
Does the presence of pain influence the descriptors used for the sensory discomfort in 
Restless Legs Syndrome? 
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ABSTRACT  
Context and Objectives: Restless Legs Syndrome (RLS) is characterised by unusual sensations in 
the legs which are described as painful in 50-80% of RLS patients. The purpose of this study 
was to examine whether the presence of pain changed the words used to describe the 
sensations of RLS.  
Methods: RLS participants (n=41) selected descriptors of their RLS sensations from a list of 
previously published RLS terms, completed the McGill Pain Questionnaire (MPQ) and the 
International Restless Legs Syndrome Severity Scale. Participants were divided according to a 
self-reported presence or absence of painful RLS sensations. The most frequently selected 
words were compared between the two groups.  
Results: The participants with painful RLS had higher MPQ scores than the non-painful RLS 
participants (median (interquartile range) 25 (15-27) vs. 15.5 (11-22) P=0.041). Apart from the 
first three words: “restless”, “uncomfortable” and “twitchy”, the overall word choice was 
different between the two groups (χ2 = 76.96, P<0.0001). Non-painful RLS was described as 
“nagging” whereas painful RLS was characterised by “cramping” and “painful”. 
Conclusion: Descriptors of RLS sensations are changed by the presence of pain which may 
indicate an aetiological difference in the patient who has painful RLS. 
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INTRODUCTION 
Restless legs syndrome (RLS) is a condition characterised by an urge to move in response to 
unusual sensations normally experienced in the legs. The descriptors used in the diagnostic 
criteria lack formal characterisation and do not take the presence of pain into consideration. 
The original descriptions of RLS sensations as parasethesia (non-painful) and dysesthesia 
(painful) did allow for these two groups but these terms have now been discontinued.  
 
Varying numbers of RLS patients describe their symptoms as painful (1) and the McGill Pain 
Questionnaire (MPQ) has been used to quantify and qualify these sensations (2,3). The 
alleviation of RLS symptoms with analgesic medications, amongst other treatments, indicates 
that pain pathways may be involved in the sensations associated with RLS (4). RLS patients 
have also been shown to have amplified nociceptive processing and increased pain sensitivity 
(5,6). The presence of pain in patients with RLS may also confound the description of RLS 
sensations. The purpose of this pilot study was to determine if the presence of pain changed 
the preferred description of RLS sensations in an English speaking South African sample of 
patients with RLS. 
 
METHODS 
Participants 
Participants were recruited on a voluntary basis by local advertisement and were asked to 
answer a screening and basic demographics questionnaire. Participants were included in the 
study if they answered all four essential diagnostic RLS questions as defined by International 
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Restless Legs Syndrome Study Group (IRLSSG) in the affirmative (7), had no history of known 
secondary causes of RLS and were fluent in English. Ethical clearance (clearance number 
M070452) was obtained from the University of the Witwatersrand Human Research Ethics 
Committee and participants signed a written informed consent form.   
 
Study design 
The participants were each given a randomly arranged list of RLS terms (n=113) derived from 
the literature and the internet (8) and were asked to select as many words as they wanted to 
describe their RLS sensations. Each participant was also asked to complete the International 
Restless Legs Syndrome Study group (IRLSSG) Severity Scale and to complete the McGill Pain 
Questionnaire (MPQ). On the MPQ, participants were told to select one word per group that 
was relevant to their RLS sensations and leave out groups that had no relevant words. 
Participants were allocated to the painful or non-painful RLS groups based on the answer to 
the question “Would you describe your RLS sensations as painful?” 
 
Data analysis  
All data were non parametric and are represented as median (interquartile range) unless 
otherwise stated. The characteristics (e.g. MPQ scores) of the painful and non-painful groups 
were compared using a Mann-Whitney test. Spearman’s correlations were performed between 
the MPQ score and the age-of-onset; IRLS severity score and RLS duration. The five most 
frequently selected words for both the painful and non-painful groups were compared using a 
Chi2 test. Post-hoc analysis for individual words was done using a Fisher’s exact test with 
Bonferroni correction.  
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  RESULTS 
Participant information 
Forty one participants (76% females) fulfilling all four of the essential RLS diagnostic criteria, 
were included in the study. The characteristics of all the participants, as well as when divided 
according to the presence or absence of painful RLS sensations are shown in Table 1. Most of 
the participants (63%) were treatment naive, 10% had previously tried dopaminergic therapy 
and 27% had tried over the counter remedies. No patients had taken treatment for their RLS in 
the week prior to the study. 
 
Painful compared to non-painful RLS 
The participants who stated that their RLS sensations were painful had higher scores (greater 
levels of pain) on the MPQ than the participants who had non-painful RLS (Table 1). There were 
no other significant differences between the two groups. The word choices overall were 
significantly different between participants with painful and non-painful RLS (Chi2 = 76.96, 
p<0.0001) (Figure 1). The most frequently selected words for both groups were “restless”, 
“uncomfortable” and “twitchy”. “Nagging” was more likely to be chosen by patients with non-
painful RLS and “cramping” and “painful” more likely to be chosen by patients with painful RLS 
(Figure 1). “Painful” was only the fifth most frequently selected word by the pain group and 
was not selected by the non-painful group. 
 
There were no significant correlations between the MPQ score and: age-of-onset (r=0.2141, 
p=0.1789); IRLSSG severity score (r=0.1056, p=0.5109) or duration of RLS symptoms 
(r=-0.1846, p=0.2480). 
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DISCUSSION 
In this group of RLS sufferers 25% complained that their RLS was painful which was validated 
by the higher MPQ pain score in this group of patients. The presence of pain and the MPQ 
score was not associated with RLS duration, age of RLS onset, RLS severity or presence of 
positive family history. The first three words chosen were common for both groups. After 
those three participants with non-painful RLS were more likely to describe their sensations as 
“nagging” whereas participants with painful RLS chose “cramping” and “painful” to describe 
their sensations.  
 
The participants in this pilot study represent a small sample of English speaking South Africans 
with RLS and the findings may differ in other cultures and language groups. The majority of our 
participants suffered from mild to moderate RLS and patients with severe RLS may choose 
different words. 
 
Despite dividing the participants according to the presence or absence of pain, the most 
frequently selected word in the painful RLS group was not in fact “painful” although the 
proportion of participants selecting this word was significantly higher than in the non-painful 
group. The first three words chosen were the same for both groups which implies that the 
presence of pain would not influence the diagnosis of RLS. After the first three words there are 
significant differences in word choices between the two groups.  
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This is the first study to show differences in the descriptors when patients with RLS have 
painful sensations. Different descriptors may indicate a difference in aetiology as occurs in 
postoperative pain (9). This may imply that the presence or absence of pain indicates two 
phenotypes of RLS. The potential impact of this finding on the aetiology, treatment, course and 
measurement of RLS requires further study.  
 
The presence of pain, whether subjective or by the MPQ, in this group of people with RLS did 
not correlate with severity of the RLS measured by the IRLSSG Severity scale. This severity scale 
primarily measures the impact of RLS on a patient’s daily life (7), does not measure the severity 
of the actual sensations and has no specific pain related questions. Thus either other measures 
need to be devised to assess the severity of the actual sensations which may need to include a 
question on the severity of pain as well, or the presence of painful sensations does not 
increase the impact of RLS on daily life. 
 
In conclusion, the word choice in patients with RLS appears to vary according to the presence 
or absence of painful RLS sensations which may support the idea of RLS as a disorder with 
multiple phenotypes. Future research should take cognisance of patients presenting with 
painful RLS as this may be an important confounding factor. More research needs to tease out 
possible relationships between RLS and pain.  
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Table 1: Characteristics of RLS participants divided by the presence or absence of painful 
symptoms   
 
 Total Non-painful Painful P value 
Number 41 30 11 - 
Male: female (n:n) 11:30 8:22 3:8 1.00 
Age (years) 50 (39-58) 49 (31-58) 51 (44-59) 0.47 
Duration of RLS (years) 15 (6-28) 16 (7-29) 12 (4-31) 0.36 
Age of  RLS onset (years) 25 (18-38) 25 (18-36) 35 (16-50) 0.39 
RLS severity 20 (16-25) 19 (15-25) 23 (16-28) 0.20 
MPQ score 17 (11.5-25) 15.5 (11-22) 25 (15-27) *0.04 
Family history (%) 39 40 36.4 0.72 
All data represented as median (interquartile range). P values represent comparisons between 
painful and non-painful groups using the Mann-Whitney test. Gender and family history 
comparisons using Fishers exact test. 
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Post hoc analysis for word choice comparing painful to non-painful sensations by Fishers exact 
test with correction for multiple comparison: *P=0.0006 nagging; **P=0.0003 cramping and 
painful 
Figure 1: Word choices of RLS patients with painful or non-painful RLS sensations. 
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ABSTRACT 
The Suggested Immobilization Test (SIT) was developed as an objective, diagnostic tool to 
quantify motor restlessness (periodic limb movements, PLM) associated with Restless Legs 
Syndrome (RLS). There has been limited research exploring the relationship between 
discomfort, pain and motor activity associated with RLS during the SIT. 
Sixteen RLS patients and eight control participants completed the International Restless Legs 
Syndrome Study Group Severity Scale (IRLS) and the SIT with bilateral recordings of tibialis 
anterior EMG (SIT PLM index), as well as pain and discomfort visual analogue scales every five 
minutes for the 60 minute duration of the SIT. The mean discomfort score had the ability 
to discriminate between RLS and control participants (P=0.003) however the PLM index did not 
(P=0.752). RLS patients were then split according to the presence or absence of PLM and 
according to the IRLS severity scores. Both RLS groups had similar levels of discomfort which 
were greater than the controls however the RLS patients with PLM had higher pain scores 
(P<0.01, Friedman test) than both the RLS without PLM and controls. Patients with severe RLS 
had significantly higher discomfort and pain scores than patients with mild RLS. Despite rating 
significant levels of discomfort, the majority of the RLS patients did not exhibit PLM possibly 
suggesting a disconnect between the sensory and motor components of RLS. This suggests that 
the SIT is a good objective diagnostic measure only in a specific group of patients with RLS. 
Keywords: Pain, discomfort, periodic limb movements, severity 
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INTRODUCTION 
 
Restless legs syndrome (RLS) is a sleep related movement disorder characterised by an urge to 
move often in response to uncomfortable or painful sensations experienced in the legs. 
Literature indicates that the need to move is more useful diagnostically than the 
“uncomfortable and unpleasant” sensations, which may or may not accompany the urge to 
move [1]. The link between the sensations and the motor component is further confirmed by 
relief after voluntary movement [2] and the exacerbation of symptoms during periods of 
inactivity or sleep [3]. One way of assessing this link is by using the Suggested Immobilization 
Test (SIT). The SIT provokes RLS sensory symptoms (as per the diagnostic criteria) as well as 
involuntary movements known as Periodic Limb Movements (PLM) [4]. To date, the only 
sensation measured during the SIT has been discomfort [5-7]. RLS symptoms have also been 
described as painful in between 40 and 80% of RLS patients [8]. The success of opioid 
treatment, the ability of patients to measure RLS symptoms on a scale for pain [9] and that RLS 
patients have also been shown to have amplified nociceptive processing and increased pain 
sensitivity [10,11] implicate the pain pathways in the pathophysiology of the sensory 
symptoms of RLS [9,12]. 
 
Very little research has been published on the relationship between the sensory and motor 
components of RLS and PLM during the SIT and that which is available shows contradictory 
results. Therefore, the objective of this study is to explore the relationship between sensory 
symptoms, including pain and discomfort, and motor activity during the SIT. 
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METHODS 
Screening and participant selection 
Participants with RLS were recruited on a voluntary basis by local advertisements. They 
completed a questionnaire with the four essential RLS diagnostic criteria questions as defined 
by the International Restless Legs Syndrome Study Group (IRLSSG) [13]. To confirm the 
diagnosis of RLS subjects had to answer all four RLS diagnostic questions in the affirmative to 
be included in the RLS group. They provided basic demographic data and excluded, on history, 
any known secondary causes of RLS or evidence of other sleep, pain or neurological disorders. 
No physical examination of the patients was conducted. Control participants answered the 
four RLS diagnostic questions in the negative, were clear of other sleep disorders and could be 
age and gender matched to the RLS participants. The RLS patients then completed the 
International Restless Legs (severity) Scale (IRLS). Each participant was questioned regarding 
their family history of RLS and a positive family history was recorded if the participant could 
accurately recall a family member reporting RLS fulfilling all four of the diagnostic criteria. 
Participants were asked to refrain from caffeine intake on the day of the study. Ethical 
clearance (clearance number M070452) was obtained from the local Ethics Committee and 
participants signed a written informed consent form. All data from participants were coded in 
order to preserve participant anonymity. 
 
Suggested Immobilization Test 
RLS patients and control participants completed the same Suggested Immobilization Test (SIT) 
regime for an hour in the evening starting between 20:00 and 21:30pm [4]. The participants sat 
upright (with a back support) with their legs outstretched resting on the bed. Silver chloride 
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surface electrodes (Bluetrode ASF 40x40mm) were attached bi-laterally to the tibialis anterior 
(active electrode 10cm inferior to patellar border, reference electrode 5cm distal to that) and 
ground electrodes attached proximal to the femoral epicondyle. Participants were asked to try 
and limit their voluntary movements as much as possible for the duration of the test (but could 
move if they needed to) and were monitored to ensure they did not fall asleep. Periodic limb 
movements (PLM) were scored according to the criteria established by Michaud [14] and the 
SIT PLM index was calculated for the hour of immobility.  No concomitant or overnight EEG 
recordings were taken. 
 
Visual Analogue rating Scales (VAS) 
Sensory symptoms were assessed every five minutes for the hour long duration of the SIT using 
two Visual Analogue Scales of 100mm each; one for pain and the other for discomfort. The 
anchors for the pain VAS were ‘no pain’ and ‘most severe pain’ and the anchors for the 
discomfort scale were ‘no discomfort’ and ‘most severe discomfort’. Participants were asked to 
make a mark on the line between the two anchors which corresponded to their perceived level 
of pain or discomfort and to differentiate feelings of pain from discomfort. The length of the 
line segment from the no pain or no discomfort anchor to the mark was measured in mm and 
recorded as the pain or discomfort score. The mean pain and discomfort scores were 
calculated as the average value of the respective scores recorded every 5 minutes. 
 
Data analysis 
All the data was treated as non parametric and is presented as median and interquartile range 
(unless otherwise stated). Groups were compared using either Mann Whitney or Kruskal-Wallis 
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with a Dunn’s multiple comparison post hoc test. The VAS scores were plotted over the hour 
and compared using the Friedman’s test with Dunn’s multiple comparison posthoc test. 
Correlations between variables were done using Spearman’s rank correlations.  
 
RESULTS 
 
Participant demographics 
Sixteen RLS patients, fulfilling all four of the essential RLS diagnostic criteria, and eight healthy 
age matched control participants were included in this study (Table 1). Thirteen of the sixteen 
RLS patients were treatment-naïve, one had discontinued dopaminergic treatment 
(Pramipexole) due to adverse side effects months before the study and two stopped their RLS 
medication (Pramipexole and Levodopa) a week before the night of the study. The RLS patients 
had a typical gender split and a wide range of RLS severities, duration of symptoms and age of 
onset. There were no significant differences between these variables. 
 
During the SIT, three RLS patients had PLMs (index 42 ± 16), while the other thirteen RLS 
patients did not display PLMs. Seven of the eight control participants did not exhibit PLM. 
Subsequently, the RLS patients were split according to the presence (RLS with PLM) or absence 
(RLS without PLM) of PLM. Table 2 presents the characteristics of the RLS patients split 
according the presence or absence of PLM. The RLS with PLM patients had a longer duration of 
RLS (P=0.036) and higher PLM index (P<0.01) compared to the RLS without PLM patients. There 
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were no significant differences in any other demographic variables between the RLS patients 
with PLM compared to those without PLM. 
 
The RLS patients were also divided according to the IRLS severity scores. Patients were 
assigned to the mild RLS group if they scored 20 or less and the severe group if they scored 
over 20. Six patients were included in the severe RLS group and had significantly greater RLS 
severity than the ten patients with mild RLS (P=0.0002). There were no other significant 
differences between the two groups (Table 2). 
 
PLM index 
There was no significant difference between the PLM index of the total RLS group and control 
participants (P=0.752, Mann Whitney test) or between the RLS patients without PLM and 
control participants (P >0.05). The PLM index of the RLS patients with PLM was significantly 
greater than the PLM index of both RLS patients without PLM (P < 0.01) and control 
participants (P < 0.001). The PLM index was not significantly different between the mild and 
severe RLS groups (P=0.4923). 
 
Discomfort and pain curves 
The RLS patients as a group compared to the control subjects had significantly greater 
discomfort but not greater pain scores during the SIT (P=0.003 and P=0.131 respectively, 
Friedman test, Dunn’s Multiple Comparison posthoc test). When the RLS group was divided 
according to the presence or absence of PLM the level of discomfort was not significantly 
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different from each other but both groups experienced significantly more discomfort than the 
control participants (Figure 1A).  
 
The RLS patients with PLM had significantly greater pain scores than the control participants 
(Figure 1B) and the RLS patients without PLM experienced significantly less pain than the RLS 
patients with PLM. There was no significant difference between the pain scores of the RLS 
patients without PLMs and the control participants (Figure 1B).  
 
The severe RLS group had significantly greater discomfort and pain scores than both the mild 
RLS group and the control participants (Figure 2 A and B). The mild RLS group experienced 
significantly greater discomfort but not pain compared to the control participants (Figure 2 A 
and B). 
 
In the RLS patients with PLM, there is a rapid increase in the discomfort score after 35 minutes 
and the pain score from 40 minutes. In the severe RLS group, the discomfort score 
progressively increases but this same pattern of evolution is not seen in the mild RLS group or 
in the pain scores for either group. 
 
Correlations 
Correlations between subjective measurements and motor activity were performed on the 
combined group of RLS patients only due to the small numbers in the RLS with PLM group. 
There was a significant relationship between the mean discomfort and mean pain scores for 
 
 
111 
 
RLS patients(r= 0.6407, P= 0.0075) as well as between the mean discomfort and RLS severity 
score (r= 0.5335, P= 0.0333). There was no correlation between the RLS severity score and the 
mean pain score (r= 0.3832, P= 0.1429). Motor activity (PLM index) could not be used in 
correlation analysis due to the lack of PLM in the majority of subjects. 
 
DISCUSSION  
In this cohort of RLS patients, the majority of the patients had no PLM during the SIT despite 
rating increasing levels of RLS discomfort. Subsequently the RLS patients were divided 
according to the presence or absence of PLM. The RLS patients without PLM were 
distinguished from the RLS patients with PLM by significantly lower pain scores and a 
significantly shorter duration of RLS symptoms. Patients with significantly greater severity of 
RLS also scored significantly higher discomfort and pain scores compared to patients with mild 
RLS and the severity score correlated to the mean discomfort score but not the mean pain 
scores. There was, however, a positive correlation between pain and discomfort in all RLS 
patients during the SIT. To our knowledge, this is the first study to have included a VAS pain 
scale to record pain symptoms during the SIT. 
 
The main and obvious caveat of this study is that of the extremely small sample size of the RLS 
patients with PLM and the wide interquartile range of the results. We are therefore cautious 
not to draw conclusions based on this small sample. Our results may differ from those 
observed in other SIT studies based on differences in the population dynamics. On average, the 
RLS participants in this study appear to be younger, with a relatively early onset of RLS 
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resulting in a longer RLS duration than reported in other studies. Of the other studies that 
reported severity ratings, the severity of RLS in our participants is on a par with these studies.  
 
There is controversy regarding patients who have RLS symptoms without PLM. In some studies 
the PLM index has been shown to discriminate RLS patients from control participants [5,6,15]. 
The presence of PLM in the diagnosis of RLS is considered essential by some authors, but other 
studies confirm our data by showing that not all RLS patients have evident PLM [2,4,15]. The 
PLM index criteria for distinguishing between RLS and control subjects also do not seem to be 
well defined and ranges from 40 PLM/hour [4] to 12 PLM/hour [16] to differentiate between 
RLS subjects and healthy controls. Discrepancy between the cut off points may be because of 
the heterogeneity of RLS patient groups and the unpredictable appearance of PLM during the 
SIT as seen in our group of participants. A lot more research is required to clarify the PLM 
criteria during the SIT in patients with RLS. 
 
Regarding the presence of PLM to diagnose RLS should not be supported as PLM are a common 
but non-essential, supportive RLS diagnostic feature whereas the sensory component (i.e. 
discomfort) is an essential part of the diagnostic criteria. The discomfort scores in our study 
better distinguished the RLS group from control subjects compared to the PLM index, similar to 
a previous study [5]. There is evidence that the number of PLM plateau after 35 minutes (at 
approximately 10 PLM/5 minute interval) of the SIT whereas the sensory symptoms continued 
to increase, implying a dissociation between the sensory and motor events [6,17]. We could 
not test this in our patient sample due to insufficient numbers of PLM. The discomfort score 
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which distinguished all RLS patients (with and without PLM) from controls may therefore be a 
more useful measure than the PLM index in diagnosing RLS. 
 
The disconnect between the discomfort of RLS and PLM during the SIT in our study does not 
seem to occur with pain and PLM, as pain increased with increasing PLM numbers for the RLS 
patients with PLM. While one study did show increasing discomfort and increasing PLM 
numbers throughout the SIT, without any correlation between these two variables [6], the 
same group also showed that there is a correlation between the mean SIT discomfort and PLM 
[5]. The authors speculate that the discrepancy between the discomfort and PLM may be due 
to patients not voluntarily moving in response to discomfort (as per the SIT instructions), 
indicating a possible level of voluntary control over PLM. These studies lacked any 
measurement of pain during the SIT and did not differentiate between pain and discomfort.  
 
Our participants with RLS but without apparent PLMs had a significantly shorter duration of 
RLS (11.5 years (range 2-30)) than those with PLM group (32 years (range 20-32)). It is possible 
that in our population PLM and pain become more common features as the disorder 
progressed. In contrast, two other articles focusing on the SIT where patients with RLS had 
PLM much shorter durations of RLS symptoms were reported of 4.9 ± 4.1 years [7], 2007) and 
9.1 ± 2.1 years [18]. The relationship between PLM, pain and duration of RLS symptoms 
deserves further exploration. 
 
There appear to be complex relationships between the sensory and motor features and 
measures of severity in RLS. We showed a correlation between the level of discomfort and the 
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severity which has been noted in one other study [7]. Despite the correlation between the 
mean pain and discomfort scores the mean pain score did not correlate with the severity in 
this study as shown in previous studies9. The lack of relationship between pain and severity 
may be because while patients can experience severe discomfort which scores highly on the 
severity scale not all RLS patients experience painful symptoms. The differences could be due 
to the severity scale not reflecting the intensity of the actual sensory symptoms but rather a 
measure of their impact and not accounting for painful RLS. The presence of pain, as an 
additional sensory symptom, may not exacerbate the impact of the severe discomfort of RLS. 
However, the patients with severe RLS reported significantly greater pain during the SIT than 
both the patients with mild RLS and the control participants. These differences in pain were 
most apparent in the latter part of the SIT (Figure 2B) and thus comparisons at different time 
points could be more sensitive than using the mean pain score. 
 
These conflicting relationships are possibly the result of differences in underlying 
pathophysiology for RLS and further support the proposal that the presence or absence of PLM 
in patients with RLS may indicate two different phenotypes. The RLS patients with PLM seem 
to have a different demographic profile particularly regarding the gender split and family 
history of RLS to the RLS patients without PLM. It is important that these under-investigated 
intricacies, relating RLS to PLM and pain, are explored further to develop a fuller understanding 
of the aetiology of RLS.  
 
In conclusion, these results suggest that the motor component of the SIT is not a good, stand 
alone, objective measure for RLS as not all RLS patients who fulfil the diagnostic criteria for 
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moderate RLS exhibit PLM on the SIT. The possibility of different phenotypes in RLS related to 
PLM and pain should be explored.  
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Table 1: Characteristics of Restless Legs Syndrome (RLS) patients and healthy control 
participants. Data are represented as median (range). 
 
 Control RLS patients 
Sample size 8 16 
Male: female (n:n) 4:4 5:11 
Age (years) 51 (25-57) 45 (24-59) 
Duration of RLS (years) n.a. 15 (2-32) 
Age of  RLS onset (years) n.a. 25 (12-56) 
RLS severity n.a. 19.5 (6-29) 
Family history (%) 0 44 
Treatment (n) n.a. 3 
SIT PLM index 0 (0-7) 0 (0-59) 
SIT, Suggested Immobilization Test. PLM, Periodic Limb Movements. 
 
 
Table 2: Characteristics of Restless Legs Syndrome (RLS) patients with and without Periodic 
Limb Movements (PLM) and mild and severe RLS. Data are represented as median (range). 
 RLS patients 
 
with PLM Without PLM Mild Severe 
Sample size 3 13 10 6 
Male: female (n:n) 2:1 3:10 2:4 3:7 
Age (years) 55 (53-56) 40 (24-59) 39.5 (24-58) 54.5 (30-56) 
Duration of RLS (years) 32 (20-32) 11.5 (2-30)* 12.5 (2-33) 18.5 (5-32) 
Age of  RLS onset 
(years) 25 (12-56) 23 (21-36) 
20.5 (12-56) 35 (21-45) 
RLS severity 23 (15-29) 19 (6-24) 14.5 (6-20) 22.5 (21-29)** 
Family history (%) 66 38 50 33 
Treatment (n) 1 2 2 1 
SIT PLM index 39 (27-59) 0*  0 (0-39) 0 (0-59) 
SIT, Suggested Immobilization Test. PLM, Periodic Limb Movements. 
* P<0.05 compared to RLS with PLM 
** P=0.0002 compared to Mild RLS 
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A. 
 
RLS without PLM vs. control (P<0.050); RLS with PLM vs. control (P<0.001). Friedman test, 
Dunn's Multiple Comparison posthoc test.  
B. 
 
RLS with PLM vs. RLS without PLM (P<0.010); RLS without PLM vs. control (P<0.001), 
Friedman test, Dunn's Multiple Comparison posthoc test. 
Figure 1: The median (interquartile range) discomfort scores (A) and pain scores (B) recorded 
on a 100mm Visual Analogue Scale (VAS) every five minutes during the Suggested 
Immobilization Test for Restless Legs Syndrome (RLS) patients with and without Periodic Limb 
Movements (PLM) and healthy control participants. Error bars are absent from the RLS with 
PLM due to the small sample size of this group. 
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P<0.05 mild RLS vs. severe RLS and mild RLS vs. control; P<0.001 severe RLS vs. control, 
Friedman test, Dunn's Multiple Comparison posthoc test. 
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P<0.05 mild RLS vs. severe RLS; P<0.001 severe RLS vs. control, Friedman test, Dunn's 
Multiple Comparison posthoc test. 
Figure 2: The median (interquartile range) discomfort scores (A) and pain scores (B) recorded 
using a Visual Analogue Scale (VAS) every five minutes during the Suggested Immobilization 
Test for Restless Legs Syndrome (RLS) patients with mild and severe RLS and healthy control 
participants. 
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CHAPTER 6 
CONCLUSIONS 
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Restless Legs Syndrome (RLS) and Periodic Limb Movements (PLM) are well documented sleep 
related movement disorders with established diagnostic criteria. These common disorders 
affect a noteworthy proportion of the general population however the prevalence data may be 
confounded by various other conditions known to ‘mimic’ RLS and the descriptors used for RLS 
have not been formally characterized which could lead to inaccuracies in the diagnosis. Some 
reports indicate that the symptoms of RLS and PLM can have devastating consequences on the 
quality of life and wellbeing of sufferers. Although effective treatment is available, we still do 
not understand the mechanisms behind the signs and symptoms. Current treatments, 
however, are not always effective in all patients and there is also a great risk of symptom 
augmentation. To fully understand these disorders, and therefore provide a platform for even 
more effective treatments, there is a need for further research possibly employing new 
assessment tools to fill in the knowledge gaps and to provide tools for the improved diagnosis 
and monitoring of these conditions. Therefore, in this thesis I have investigated some aspects 
of the assessment of sensory and motor features of RLS and PLM with the overall objective of 
contributing to the understanding of their aetiology and improving the accuracy of diagnosis. 
Thus, the primary aims of this thesis were: to describe and characterize RLS sensations both as 
a tool to determine the aetiology and for diagnostic purposes; to objectively quantify two 
spinal reflexes as a reflection of spinal excitability in RLS patients and assess the circadian 
variations thereof, and lastly to focus on the Suggested Immobilization Test (SIT), a means of 
simultaneously assessing both the sensory and motor components of RLS and PLM, facilitating 
investigation of the relationship between them and possibly providing clues to their aetiology.     
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6.1. Sensory assessment - Descriptors of RLS sensations 
 
RLS is diagnosed based on the patient’s subjective, self-reported symptoms. However, many 
patients experience difficulty in expressing the nature of their sensations and as such they 
could be misdiagnosed if a clinician is primed to relate to only those descriptors included in the 
diagnostic criteria. Therefore, my first study investigated the word choice of 41 English 
speaking South African RLS patients who spontaneously provided descriptions of their RLS 
sensations, selected terms from pre-determined lists of RLS descriptors derived from the 
literature and then selected terms from the McGill Pain Questionnaire. The patients struggled 
to spontaneously describe their sensations, often resorting to bizarre similes such as “like the 
feeling you get at the onset of a sneeze, only in your legs” to portray the feeling. Patients were 
able to provide a much larger sample of descriptors when selecting from a large selection of 
terms previously generated and reported by RLS sufferers. While the “unassisted” spontaneous 
descriptors given by patients may be the most accurate descriptors of the sensations they are 
experiencing, patients that struggle to communicate about their sensations may benefit from a 
prompted list of words (Williams et al., 2000; McDonald & Weiskopf, 2001). Thus, suspected 
RLS patients may be able to communicate more effectively with their health care professional 
if they are provided with an appropriate list of terms known to be associated with RLS as 
identified by a substantial number of patients with confirmed RLS. 
 
Further highlighting the difficulty in precisely describing RLS sensations is that the RLS patients 
chose different words spontaneously, when prompted and from the MPQ. The MPQ, which 
contains only pain related words, was included in the study based on the results of Bentley et 
al (2007) who found that the sensory symptoms of RLS could be assessed using a qualitative 
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pain questionnaire. The relationship between pain and RLS was not confirmed by my first 
study. Only two words, ‘tingling’ and ‘nagging’ were found in common between those selected 
from the MPQ, those spontaneously offered and those selected from the established list. 
However, in the follow on study (paper two), there were clear differences in the choice of 
words between RLS patients with painful and non-painful sensations. The words “cramping” 
and “painful” were favoured by the patients with painful RLS. In a clinical setting, a patient 
complaining of cramping and painful sensations in their legs may be diagnosed with a condition 
that mimics RLS such as leg cramps or peripheral neuropathy, resulting in a marked under-
diagnosis of RLS (Hening et al., 2004b). Coupling these words (painful and cramping) with the 
other commonly selected word ‘restless’, may assist in determining the RLS diagnosis. These 
results are consistent with Ekbom’s original proposal that there may be two main forms of RLS, 
one characterized by painful symptoms and the other by non-painful parasethesia (Ekbom, 
1945). 
 
Alternatively, the RLS prevalence statistics could be overestimated as the diagnostic criteria for 
RLS, as they stand, are unable to exclude conditions that mimic RLS (Hening et al., 2009). There 
is a clear need for improved assessment of RLS and conditions that mimic this condition in 
order to provide better differential diagnoses. The key may lie in the diagnostic descriptors and 
differences in the word choices defined by each condition which could potentially aid in 
distinguishing each of these. Future research is required to characterise the descriptors of the 
conditions that mimic RLS to facilitate the differentiation of these conditions from RLS.  
 
The phrasing of the diagnostic criteria, although a purely semantic exercise, may influence a 
clinician’s diagnosis of a patient. Physicians may be primed to relate to the current wording 
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and may not recognize other, more unusual yet valid, descriptors. Also, different phenotypes 
may influence a clinician’s diagnosis of RLS and have implications for the possible treatment 
options provided. For example, patients who have painful RLS may respond better to opioid 
treatment than those without painful RLS symptoms. Thus, it is important that the clinicians 
are provided with the most accurate set of descriptors (which are possibly RLS phenotype 
specific) for RLS which will enable them to recognize RLS and optimize the patient’s treatment 
according to the RLS phenotype. More research is needed investigating the relationship 
between pain and RLS and particularly the responses to different treatments. 
 
The choice of descriptors used by patients with RLS may be affected by different languages and 
cultural influences which in turn may also affect prevalence estimations. The terms patients 
use to describe their symptoms may be culture specific. For example, a North American patient 
may be more inclined to select the phrase “Elvis legs” than an African patient from a rural 
community who may be unfamiliar with the pop icon reference. The diagnosis of RLS may be 
improved by overcoming language and cultural barriers and obtaining differential diagnostic 
terms for conditions mimicking RLS. There is a definite need to repeat this study in different 
English speaking populations and translations into other languages. Ultimately, an 
international, large scale, multicultural study is required to determine the most accurate 
diagnostic descriptors for RLS which could be used throughout the world.  
 
One of the essential components of the diagnostic criteria is that the patient experiences an 
“urge to move” in response to “uncomfortable and unpleasant sensations” in their legs. The 
‘urge to move’ can present independently of associated uncomfortable sensations but in some 
patients the sensory and motor component cannot be separated (Allen et al., 2003). The 
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current emphasis is that the urge to move is more diagnostically useful than the actual 
sensations, which is supported by my research showing that motor phrases were the dominant 
choice. Karroum et al (2012) simultaneously published similar research to paper one included 
in this thesis but in their discussion they challenge the idea that there is a pure motor form of 
RLS. The majority of patients in their study could provide sensory verbal descriptors to 
adequately describe their condition. In fact, the authors only present the sensory and affective 
descriptors provided and do not report if the RLS patients spontaneously offered any 
movement-related descriptors (Karroum et al., 2012). Further research is required to 
determine whether in fact a pure motor form of RLS does exist.  
 
Whether they occur with the sensations or independently, the motor symptoms are a common 
feature in RLS. RLS symptoms are relieved by motor activity and exacerbated by inactivity, 
which emphasizes the contribution of the motor system in RLS. As such, the motor component 
of RLS is the focus of the next section.  
 
6.2. Motor assessment - Spinal excitability in RLS patients  
 
My second study focused on the assessment of two spinal reflexes, the H-reflex and the 
patellar reflex, as a reflection of spinal excitability in RLS patients measured at two different 
times of the day. For simplicity in addressing the issue of spinal excitability, I shall first discuss 
the differences observed in spinal excitability between RLS and control subjects independently 
of circadian timing, and in the section to follow address the circadian variations in spinal 
excitability.  
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Using neurophysiology and kinematics I found that the patellar amplitude and knee angular 
displacement were smaller in the RLS group compared to the control group, but that the knee 
angular velocity and all of the H-reflex parameters (latency, amplitude and H/M ratio) showed 
no difference between the two groups. The patellar reflex data indicates that RLS patients 
exhibit spinal hypoexcitability in comparison to healthy control subjects. However, the H-reflex 
data contradicts this and suggests that there is no difference in spinal excitability between 
these two groups. The study does not exclude the possibility that changes in the patellar reflex 
could be due to changes outside the spinal cord, such as in the muscle spindle or nerve fibres, 
or that methodological problems contributed to these findings. My original hypothesis and 
that of others in the literature, that RLS patients would exhibit spinal hyperexcitability in 
comparison to healthy control subjects, is not supported by my data. 
 
The possible reasons why the two reflexes showed different results include that there are 
variable influencing factors in both stimulating and recording each reflex or that there are 
different spinal segments involved. Segmental spinal excitability changes may account for the 
differences noted between the H-reflex and patellar data in this thesis. The H-reflex of the 
lower limb tests the functionality of the peroneal or tibial nerve and primarily traverses spinal 
segments L5, S1 and S2 whereas the patellar reflex is innervated by the femoral nerve which 
reflects spinal segments L2-L4. Thus the two reflexes reflect the function of different spinal 
segments. 
 
Tendon reflexes are subject to the influence of gamma motor neurons and changes in muscle 
spindle sensitivity which are in themselves segmental. Although speculative, my data would 
therefore suggest that RLS does not cause global hyperexcitability of the spinal cord but that 
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any affects are rather more localised. Given the differences in reflexes reflecting different 
spinal levels, it is important for this to be taken into account in research that assesses spinal 
excitability in RLS.  
 
The parameters of the H-reflex that I focused on, namely H-latency, H-amplitude and H/M ratio 
have fairly consistent findings in the context of RLS patients. Concurring with my findings for 
the H-reflex, several other studies have shown that there were no differences between RLS 
and control subjects measuring different aspects of the H-reflex (Bucher & Trenkwalder, 1996; 
Akyol et al., 2003; Rijsman et al., 2005; Scaglione et al., 2008). Thus, added to the results from 
my H-reflex data, neurophysiological testing of these parameters does not reveal changes in 
spinal excitability in RLS patients, which is contrary to the widely accepted spinal 
hyperexcitability theory. 
 
The body of evidence supporting spinal hyperexcitability in RLS and PLM patients that is 
reviewed in chapter 1 (section 1.3.3. and section 2.2.3.4.) primarily focused on results obtained 
from the H-reflex (Wechsler et al., 1986; Martinelli et al., 1987; Rijsman et al., 2005; Scaglione 
et al., 2008) and the flexor reflex (Bara-Jimenez et al., 2000) showing excitability of the H-reflex 
and disinhibition of the spinal circuitry. Different H-reflex parameters and the use of a different 
reflex (patellar) could possibly account for the apparent conflict between my data and that in 
the literature. Other studies, also reviewed in chapter 1, have also shown that not all the 
evidence indicates that RLS and PLM patients exhibit spinal hyperexcitability, as is the case in 
my study.  
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It has been shown in studies looking at spinal excitability states in spasticity (which is normally 
characterised by hyperreflexia), that hyperexcitability may depend on the site of the lesion and 
it may not be a global spinal phenomenon. Zhang et al (2000) demonstrated in spastic multiple 
sclerosis patients that the patellar reflex has increased gain and decreased contraction time 
which is consistent with spinal hyperexcitability (Zhang et al., 2000). However, Salazar-Torres 
et al (2004) looked at the biceps brachii stretch reflex in spastic stroke subjects and found 
decreased reflex amplitude compared to controls. Thus, cerebral lesions (stroke) rather than 
the spinal cord are not always associated with hyperreflexia. Therefore, similar to what might 
be occurring in RLS and PLM, the evidence from these previous two studies indicates that 
hyperexcitability may not be a global spinal phenomenon. 
 
The results from the patellar reflex testing in my study concur with the proposition that 
hyperexcitability may not be a global spinal phenomenon in RLS patients. Thus far, research 
has either indicated spinal hyperexcitability or no changes in the state of spinal excitability in 
RLS patients. By introducing the use of the patellar reflex, which has not been examined in the 
context of RLS and PLM patients, the discovery that it is hyporeflexive in these subjects is new 
to the field. Not only is this contrary to the spinal hyperexcitability concept, but it suggests an 
abnormality opposite to that which has been described in the RLS literature, but that has been 
demonstrated in other conditions. 
 
Given the conflicting neurophysiology literature specifically in the field of RLS and PLM, the use 
of kinematics analysis was introduced to provide an objective measure of visually observed 
reflex parameters. The only previous work using biomechanics to assess the patellar reflex in 
any context used accelerometry and not video kinematics. Mamizuka et al (2007) using a 
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triaxial accelerometer determined that the patellar reflex in spastic patients had greater peak 
angular speed than healthy control subjects (Mamizuka et al., 2007). Unfortunately, the 
differences in the averages were smaller than the standard deviations which could be 
attributed to a possible experimental flaw and thus, although promising, the use of 
accelerometry for the assessment of reflexes requires further validation. 
 
The novel measures that I have introduced to look at the state of spinal excitability have 
provided interesting, but as yet unexplainable, results. I can only speculate why my results (and 
that of some other authors) are contrary to the widely accepted, but not conclusively proven, 
global spinal hyperexcitability theory. Possibly RLS patients either have spinal hypoexcitability 
of certain components and thus similar global excitability to control subjects. Whether the 
lower patellar amplitude necessarily reflects a significant reduction in excitability 
(hypoexcitability) as opposed to excitability at the lower end of the range but still within 
normal limits needs to be investigated. Future studies should examine the patellar amplitude 
of RLS and PLM patients after treatment and in a much larger sample of patients and compare 
these results to conditions of known hyporeflexia to determine if in fact RLS and PLM patients 
do exhibit hypoexcitability of the patellar reflex. Conversely, the patellar reflex data I obtained 
could be reflecting hyperexcitability of inhibitory neurones which would cause attenuation in 
the patellar amplitude. However, this could not be definitively determined by the current study 
and until the spinal mechanisms are delineated in RLS we may not be able to determine this 
possibility. Assuming that my results are an accurate reflection and not a consequence of 
methodological problems, this research suggests that the aetiology of RLS and PLM is not as 
simple as a global spinal hyperexcitability in these patients. The hyperexcitability paradigm that 
has been established in the literature may be specific to discreet connections which are 
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different to the specific monosynaptic patellar reflex circuits that were tested in paper two. 
Investigating these different circuits, which may be more or less excitable is worth pursuing. 
Perhaps researching segmental excitability and intra-segmental excitability of different 
pathways within the same set of RLS patients could help determine the global state of spinal 
excitability in these patients. Further research into more specific spinal pathways, possibly 
using drugs, autopsy studies or neuroimaging techniques to isolate particular pathways, is 
required to specifically elucidate the state of spinal excitability in patients with RLS and PLM.  
 
6.2.1.  Circadian variations of spinal excitability in RLS patients 
 
Symptoms of RLS follow a circadian pattern and if one assumes that a change in the state of 
spinal excitability drives RLS symptoms, then this state should follow a circadian variation to 
reflect the change in RLS symptoms throughout the day. Thus a secondary aim of my third 
study was to assess the diurnal changes in spinal excitability. The previous section showed 
some changes in spinal excitability in RLS patients independent of circadian factors, which may 
determine whether symptoms are dominant or absent.  
 
Taking into account the time of day, the RLS patients’ patellar amplitude in the evening was 
smaller than the morning and compared to the control subjects. The RLS patients’ patellar 
amplitude had an approximate decline of 45% from morning to evening thus displaying a 
circadian variation. The control group however, did not exhibit a circadian rhythm for the 
patellar reflex. All the other reflex parameters showed no difference in the morning or evening 
between groups, and no circadian variation within either group. Therefore, during the time 
when symptoms are expressed, there are differences between RLS patients and control 
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subjects, although not in the direction expected, but when symptoms are absent, differences 
are insignificant between RLS patients and controls. Some of the patellar reflex (amplitude and 
knee angular displacement) data indicates that the RLS patients had altered spinal excitability 
during the symptom dominant evening period but expressed as hypoexcitability and not as 
hyperexcitability. However, not all of my data agree with this as the H-reflex and other 
measures of the patellar reflex show that there are no circadian changes in spinal excitability in 
RLS patients.  
 
There is evidence suggesting that some spinal reflexes have inherent circadian fluctuations 
whereas others do not. Although inconclusive, and somewhat dependent on muscle and reflex 
type, the state of the spinal cord has been shown to become both more and less excitable 
throughout the day therefore indicating that excitability changes are not a global spinal 
phenomenon. Further studies are required to determine the exact circadian variations of spinal 
reflexes and what factors contribute to the presence or absence of these circadian patterns.  
 
This is the first study looking at circadian changes of reflexes within the same set of RLS 
patients and shows circadian variations in the patellar reflex but not in the H-reflex. The 
possibility that properties of the patellar tendon change throughout the day could perhaps 
play a role in the differences observed in the patellar reflex. Pearson et al (2006) found that 
patellar tendon stiffness decreased from morning to evening and therefore the tendon should 
be more compliant in the evening (Pearson & Onambele, 2006). This, however, would not 
reflect as a smaller reflex as was the case in my research. Also, if the cause of the change in 
patellar reflex in the RLS patients was due to a change in the properties of the tendon then the 
same variation would be expected in the control group.  
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Circadian variation in spinal excitability has not been examined in patients with RLS and very 
few neurophysiology studies on patients with RLS actually take time of day into account. 
Looking at the literature at reflexes that have been tested during the time when symptoms are 
present, spinal hyperexcitability has been indicated. Impaired H-reflex excitability curves and 
vibratory inhibition depression, indicative of spinal disinhibition, and lower thresholds and 
greater spatial spread of the flexor reflex in PLM patients have been demonstrated in the late 
afternoon and during the evening (between 21:00 and 00:00) (Bara-Jimenez et al., 2000; 
Rijsman et al., 2005). These results are in comparison to control subjects but were not made 
between morning and evening measurements made within the same set of patients. 
 
As I have previously indicated, the H-reflex parameters I tested did not detect changes in spinal 
excitability. It is possible that the tests I used are not sensitive enough to detect subtle 
circadian variations, or that a far larger sample size might have shown differences. Despite this, 
there was no statistically significant circadian variation of the H-reflex in either controls or 
patients with RLS. For the first time however, my results show that RLS patients show diurnal 
fluctuations in the spinal excitability state as reflected by the patellar reflex. During the period 
when RLS symptoms are predominant, there is an altered spinal excitability reflected by the 
patellar reflex data, supporting the idea that RLS is a disorder involving fluctuations in spinal 
excitability. Future studies should focus on examining circadian variations using more sensitive 
measures of spinal excitability as well as multiple reflexes within the same patients. Again, 
researching the segmental excitability and intra-segmental excitability and whether these 
change throughout the day (in accordance with the circadian pattern of symptoms) may help 
elucidate the pathophysiology of RLS and PLM. 
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6.3. Sensorimotor assessment – Suggested Immobilization Test 
 
My fourth study looked at the relationship between the sensory (discomfort and pain) and 
motor features of RLS and PLM during the Suggested Immobilization Test (SIT). All the RLS 
patients reported significant increases in their levels of discomfort throughout the test, 
however only three of the sixteen patients presented with simultaneous PLM. The SIT has been 
proposed as an objective diagnostic test for RLS however, whether the motor activity (PLM 
index) or measure of discomfort (mean discomfort score) is better able to distinguish RLS 
patients from control subjects, is questionable.  
 
The PLM index is an objective measure of the number of PLMs presented during the SIT and 
has been shown to successfully distinguish RLS patients from controls (Montplaisir et al., 1997; 
Michaud et al., 2002a; Michaud et al., 2002b). The exact, and minimum, number of 
movements required to distinguish RLS patients from controls is debatable. One study has 
shown that a PLM index of 12 is sufficient (Haba-Rubio & Sforza, 2006), whereas another has 
proposed a much higher number of 40 (Montplaisir et al., 1998). A further problem associated 
with this method is that not all RLS patients present with PLM, as was seen in the majority of 
participants in my fourth paper. According to the above criteria, using a PLM index of either 12 
or 40, only three of the RLS patients included in my study would have been diagnosed with RLS 
(despite all the patients fulfilling the essential diagnostic criteria). PLM are a common, but non-
essential, supportive RLS diagnostic feature whereas the sensory component (i.e. discomfort) is 
an essential part of the diagnostic criteria.  
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The SIT can also be used to assess the relationship between sensory and motor features of RLS. 
RLS sensory symptoms are exacerbated during inactivity and are relieved by voluntary 
movement, suggesting a link between the two however the association is unclear. There is 
some evidence of a disconnect between the two as shown by escalating discomfort levels 
concurrent with a plateau in the number of PLM and a lack of correlation between sensory and 
motor features (Michaud et al., 2002a; Birinyi et al., 2005). We could not perform correlation 
analysis between sensory and motor components on our sample as the majority of the patients 
did not present with PLM. That, in itself, suggests that there is a disconnect at a particular level 
of PLM between these components as all the RLS patients had increasing levels of discomfort 
without associated motor activity. 
 
The lack of PLM in the majority of the RLS patients prompted me to divide the RLS patients 
according to the presence or absence of PLM. Subsequent analysis revealed that the RLS 
patients with PLM reported greater levels of pain during the SIT and had increasing numbers of 
PLM throughout the SIT compared to the patients with RLS without PLM and the control 
participants. I do recognise that the small sample size limited the analysis options and as such, 
any deductions (relating to the RLS with PLM patients) are made with some caution. These 
data do suggest however that there is a relationship between pain and PLMs. Perhaps RLS 
patients with pain are more prone to develop PLM or those with PLM are more likely to be 
associated with pain. It would be interesting to see if the descriptors selected by patients with 
painful RLS or PLMW on the SIT included more movement related terms. Also, perhaps painful 
RLS symptoms only present as the disorder progresses, given that there was a longer duration 
of symptoms in this group of patients. The relationship between pain, discomfort and PLM 
warrants further exploration. The complex associations between the sensory and motor 
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features of RLS and the appearance of PLM and pain in only some patients imply that RLS is a 
heterogeneous disorder. 
 
6.4. Concluding statement 
  
Further assessment of the sensory and motor features, both in conjunction and isolation, are 
required. New assessment techniques are essential to advance the field and tease out some of 
the current contradictory results in RLS and PLM research. Each of the studies included in this 
thesis introduce a new perspective or technique for the assessment of RLS and PLM. The 
results from the studies included in this thesis indicate that RLS is a more complex disorder 
than previously imagined. The diverse range of descriptors, including both sensory and motor 
terms, which are influenced by pain and possibly by other differences in underlying 
mechanisms, suggest that RLS is a heterogeneous disorder with different phenotypes in 
addition to those already described. The hypoexcitability of the patellar reflex shown in this 
thesis, which is contrary to the theory in the literature of spinal hyperexcitability as the 
aetiology of RLS and PLM, indicates that excitability changes of the spinal cord may not be a 
global phenomenon in these patients. Furthermore, the distinction between painful and non-
painful RLS based on the SIT PLM index and the patient’s word choice supports that RLS and 
PLM are heterogeneous disorders with multiple phenotypes. The discrepancies noted in the 
literature in each of these topics and between my results and the literature may arise from the 
assumption that there is one common pathophysiology for both the disorders. Generally the 
concept of different RLS phenotypes, although previously described, has been ignored when 
selecting patients to include in studies of this type. Much more research, using different 
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techniques including those introduced in this thesis, is required to tease out the different 
phenotypes.  
 
A statement made in a paper by Bachmann et al (2010) sums up the importance of recognising 
the different phenotypes of RLS and the implications thereof, “Differentiation of restless legs 
subtypes is of utmost clinical relevance as it enables a differentiated therapeutic approach for 
patients with RLS” (Bachmann et al., 2010). Healthcare providers and future researchers 
should take cognizance of the potential clinical and research implications of possible 
differences in underlying pathologies of RLS and PLM to overcome therapeutic difficulties and 
research complicated by multiple phenotypes. In conclusion, including new assessments of the 
sensory and motor features (as presented in this thesis) together with effective 
communication about the type of RLS sensations may improve the accuracy of diagnosis and 
strengthen our understanding of the RLS and PLM aetiology. 
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Appendix A: Restless Legs Syndrome questionnaire  
 
1. What is your age?      ________  years 
 
2. What sex are you?  male / female (circle correct one)     
 
3. What is your height?   _______ m / feet and inches (circle correct one) 
 
4. What is your weight?   ________  kg / lb.  (circle correct one) 
 
5. What ethnic group do you belong to? _______________ 
 
6.    If you are a male - what is your collar size?    ______   cm / inches (circle 
  correct one) 
 
7. Have you had a regular bedpartner for the last 2 months?   yes / no (circle 
  correct one) 
 
8. Has your bedpartner commented on you doing any of the following while asleep? (circle correct one) 
    
    Most nights Sometimes Almost never Never 
 
a. Snoring heavily and    1     2     3     4 
 regularly?  
   
b. Episodes where you      1     2     3     4 
appear to hold your breath? 
 
c. Restless sleep?      1     2        3     4 
 
d. Regular kicking of     1     2     3     4 
your legs while asleep? 
 
9. If you do not have a regular bed partner, have you ever been told that you do any of the following? 
(circle correct one) 
        
 a. Severe snoring?    Yes / No 
  
 b. Stop breathing while asleep?   Yes / No 
  
 c. Very restless while sleeping?   Yes / No 
   
 d. Legs twitching regularly while asleep? Yes / No 
 
 
 
 
 
 
10. a. Do you ever get an uncomfortable sensation in your lower legs (below the 
    knees) which urges you to move your legs after sitting still for only 15 minutes. 
    This uncomfortable sensation may come on before falling asleep, while watching 
    TV or during a long trip.        Yes / No      (circle correct one) 
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  If you answered yes to the previous question -  
 
 b. Does the sensation go away (even partly) when you move your legs?   
  Yes / No (circle correct one) 
 
c. Is the sensation worse at night – compared to the day-time? 
Yes / No  (circle correct one) 
 
 d. Does the sensation occur only when your legs are resting e.g. lying 
 down or sitting still?  Yes / No (circle correct one) 
 
 e. Is there anything eg something that you eat or drink that makes the sensation worse? 
Explain. 
 
  ____________________________________________________________  
 
 f. How many days per week does this sensation occur? _____ days 
 
 g. At what age did this sensation start?  _________  years 
 
 h. Has the type of sensation changed over time?  Explain. 
 
 ____________________________________________________________  
 
 i. Is the sensation  staying the same / getting better  / getting worse with time?  (circle correct  
one) 
 
 j. Do you know of anyone in your family who has the same sensation in their legs?       Yes / No
 (circle correct one) 
 
 k. How are they related to you i.e. your mother and/or sister?  
 
 ______________________________________________________         
  
 l. Have you ever used medication to treat this uncomfortable sensation? 
  Yes / No   (circle correct one) 
 
m. If you answered yes to question k. please list the medication tried and any effect of the 
medication. 
 
 ___________________________________________________________   
 
___________________________________________________________   
 
 
12. As a child, did you ever have pains in the shins at night-time?  
 Yes / No / Can’t remember ( circle correct one) 
 
 
13. If you answered yes to Q12: 
 
 At what age did you first have these pains? 
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  _________ years old / can’t remember 
 
 Was there anything that relieved the pain?   Yes / No / Can’t remember 
 
  If yes what was it - _____________________________   
 
 At what age did this pain in the legs go away?  
 
  _________ years old / Don’t remember / Never went away 
 
14. As a child were you ever diagnosed with a learning problem?    
 Yes/No  (circle correct one) 
 
15. If you answered yes to Q14 – indicate which of the following by placing a cross next to the correct 
one. 
   Attention Deficit Disorder  ADD 
   General concentration problem 
   Other- specify ______________________________  
 
16. Do you have a twitching or jumping sensation in your legs while awake 
 and sitting still?         
 Yes / No   (circle correct one)  
 
17. If you answered yes to Q16,  
 
 a. how often do these twitches occur? (circle the correct answer) 
   
 less than once a week / once a day / more than once a day. 
 
 b. What age were you when these twitches started? _________ years 
  
 c. Are the twitches getting worse over time / getting better over time / staying the same since 
they started? (circle the correct one)    
  
 
18. Do you have difficulty falling asleep at night more than 3 nights per week?  
  i.e. takes more than 30 minutes? Yes / No (circle correct one) 
 
If you answered yes to Q18, What do you suspect the reason to be? 
______________________________________________________________________________
__________________________________________________   
 
 
19. Do you wake up during the night and find it difficult to go back to sleep? 
 Yes / No (circle correct one) 
 
 
If you answered yes to Q19 
 
 How many nights per week? _________ nights 
 
 What do you suspect the reason to be?____________________  
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20. Do any of your relatives have a sleep problem?    Yes / No 
 
  If you answered yes to Q 20 
 
 What is your relationship to them i.e. your mother?  
 
           ________________________________________________________ 
 
21. How many cigarettes do you smoke per day? (circle correct one) 
 
 none / 1-15 per day / 16-30 per day / more than 31 per day 
 
22. How many units of alcohol do you drink per week? ( one unit would be one single tot of spirits / one 
beer / one glass of wine 
 
   ____________ units per week 
 
23. How many cups of caffeine do you drink per day? This includes coffee, tea, Cola drinks or energy 
drinks. Explain. 
 
_____________________________________________________________ 
 
 
24. How likely are you to doze off or fall asleep in the following situations after you’ve had your usual 
nights sleep: (circle one number for each) 
 
   Would never doze   Slight chance Moderate chance High chance 
 
a. Sitting and    0  1  2  3 
     reading 
 
b. Watching   0  1  2  3 
    television 
 
c. Sitting inactive  0  1  2  3 
     in a public place 
 
d. Passenger in a car  0  1  2  3 
     for an hour without 
     a break 
 
e. Lying down to rest  0  1  2  3 
    in the afternoon 
 
f. Sitting and talking  0  1  2  3 
    to someone 
 
g. Sitting quietly after  0  1  2  3 
    lunch with no alcohol 
 
h. In a car, while stopped 0  1  2  3  
     for a few minutes 
     in the traffic 
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25. Are you on any regular medication? Yes / No (circle correct one)      
 
If yes – please could you list the medical conditions that you are currently treated for in the 
space below. 
 
 _______________________________________________________   
 
 Could you please list all medication that you are currently taking including the dosage and 
number of tablets or sprays per day. 
  
 ___________________________________________________________ 
 
___________________________________________________________   
 
 ___________________________________________________________   
 
 
26. Have you ever been diagnosed or treated for the following conditions? Please circle the correct 
answer 
 
 a. Iron deficiency anemia    yes / no    If yes:  What age__________ yrs 
 
 Were you treated and what were you given? __________________ 
 
 __________________________________________________________ 
    
 Did the treatment make any difference to the restless legs?  Yes / no 
 
b. Back problems – either chronic back pain or disc problems or injury in an accident?           Yes 
/ no 
 
 If yes:  What age did it start?    ___________ yrs 
 
 Did this occur before the onset of restless legs syndrome?                
                   Yes / no 
 
 c. Renal failure    yes/no 
 
 If so what age were you?________yrs 
 
 How long did the renal failure last for? ________ Yrs/months 
 
 
For women only:     Were you pregnant while you had restless legs?       Yes/no 
 
If you answered yes:       How did the restless legs change during the pregnancy – ( you can indicate 
more than one option) 
 
They started during the pregnancy    
They stayed the same during the pregnancy 
They got worse as the pregnancy progressed 
They disappeared after the pregnancy and restarted later on. 
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Appendix D: International RLS study group severity rating scale (IRLS)   
  
 
In the past week… 
 
1. Overall how would you rate the RLS discomfort in your legs or arms? 
 
□  Very severe   □  Severe   □  Moderate  □  Mild  □  None 
 
2. Overall how would you rate the need to move around because of your RLS symptoms? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
 
3. Overall, how much relief from your RLS arm of leg discomfort did you get from moving around? 
 
□  No relief  □  Mild relief  □  Moderate relief  □  Either complete or almost complete relief   
 □  No RLS symptoms to be relieved  
 
4. How severe was your sleep disturbance due to your RLS symptoms? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
 
5. How severe was your tiredness or sleepiness during the day due to your RLS symptoms? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
 
6. How severe was your RLS on the whole? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
 
7. How often did you get RLS symptoms? 
 
□  Very often (this means 6-7 days per week) 
□  Often (this means 4-5 days per week) 
□  Sometimes (this means 2-3 days per week) 
□  Occasionally (this means 1 day per week) 
□  Rarely (this means less than 1 day per week) 
 
8. When you had RLS symptoms, how severe were they on average? 
 
□  Very severe (this means 8 hours or more per 24 hour day) 
□  Severe (this means 3-8 hours per 24 hour day) 
□  Moderate (this means 1-3 hours per 24 hour day) 
□  Mild (this means less than 1 hour per 24 hour day) 
□  None  
 
9. Overall, how severe was the impact of your RLS symptoms on your ability to carry out your daily 
activities, for example having a satisfactory family, home, social, school or work life? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
 
10. How severe was your mood disturbance due to your RLS symptoms – for  example being angry, 
depressed, sad, anxious or irritable? 
 
□  Very severe  □  Severe  □  Moderate  □  Mild  □  None 
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Appendix E : McGill Pain Questionnaire 
 
PRI: S _______ A ______ E _______ M _______ PRI (TOTAL) _______ PPI ________ 
                (1-10)         (11-15)             (16)                (17-20)                                     (1-20) 
 
 
1   2   3   4 
1. Flickering  1. Jumping  1. Pricking  1. Sharp 
2. Quivering  2. Flashing  2. Boring  2. Cutting 
3. Pulsing  3. Shooting  3. Drilling  3. Lacerating 
4. Throbbing     4. Stabbing 
5. Beating     5. Lancinating 
6. Pounding 
 
 
 5   6   7   8 
1. Pinching  1. Tugging  1. Hot   1. Tingling 
2. Pressing  2. Pulling  2. Burning  2. Itching 
3. Gnawing  3. Wrenching  3. Scalding  3. Smarting 
4. Cramping     4. Searing  4. Stinging 
5. Crushing 
 
 
 9   10   11   12 
1. Dull   1. Tender  1. Tiring  1. Sickening 
2. Sore   2. Taut   2. Exhausting  2. Suffocating 
3. Hurting  3. Rasping 
4. Aching  4. Splitting 
5. Heavy 
 
 
 13   14   15   16 
1. Fearful  1. Punishing  1. Wretched  1. Annoying 
2. Frightful  2. Gruelling  2. Blinding  2. Troublesome 
3. Terrifying  3. Cruel      3. Miserable 
4. Vicious     4. Intense 
5. Killing     5. Unbearable 
 
 
 17   18   19   20 
1. Spreading  1. Tight   1. Cool   1. Nagging 
2. Radiating  2. Numb  2. Cold   2. Nauseating 
3. Penetrating  3. Drawing  3. Freezing  3. Agonising 
4. Piercing  4. Squeezing     4. Dreadful 
5. Torturing 
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Appendix F: List of RLS descriptive words 
 
  
 
 
 
 
 
 
 
Aching Fizzy Pulsating Traction 
Afflictive  Fluttery Queasy  Trembling  
Agitated Frustrated Quivering Troublesome 
Agonizing  Funny  Raw Tugging 
Alive Ghostly Restless Twinging 
Anesthetized Gnawing Scratchy Twitchy 
Animated Grabbing Searing Uncomfortable 
Antsy Heavy Shaky Uneasy 
Apprehensive Hurting  Sharp Unnerved 
Asleep Hyper  Shock-Like Unpleasant 
Awkward Irritating Skittish Unquiet 
Biting Itchy Slithering  Unyielding 
Bizarre Jerky Smarting Uptight  
Burning Jiggly Sore Wearisome  
Buzzing Jittery Squirming Weird 
Caustic Jumpy Stinging Wiggly 
Clutched Lively Straining Wired 
Cramping Mysterious Strange Worming  
Creepy-Crawly  Nagging Suffering Worried 
Dead Numb Supernatural Wrenching 
Disagreeable Ouchies Tearing Wriggling 
Distressing Overwrought Tender Writhing 
Drawing Painful Tense Yanking 
Effervescent Panicky Thorny   
Electric Peculiar Throbbing   
Energetic Piercing Tickling   
Excited Pounding Tight   
Exploding Pressured Tingling   
Fidgety Prickling Tired   
Fiery  Pulling Toiling   
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Appendix G: List of descriptive phrases 
 
 
Ants/spiders/restless grasshoppers in the legs 
Anxiety in your legs 
Blood racing through your legs 
Crazy legs 
Elvis legs 
Feels like your legs want to jump off your body 
Giggly legs 
Hyped-up 
Jimmy legs 
Just an urge to move 
Legs are in a tizzy 
Legs have too much energy/are full of energy 
Legs need to stretch 
Legs need to walk/jog 
Legs want to move on their own/won’t be still 
Like being stung by 20 mosquitoes and not being able to scratch 
Like insects biting the inside of your legs 
Like jumping beans in your legs 
Like something is poking your legs 
Like something popping inside your legs 
Need to handle your legs 
Need to kick out your legs 
Nervous legs 
Pepsi/cola/soda bubbles in the veins 
Pins and needles 
Runaway legs 
The got to moves 
The heebie jeebies 
Water moving through your legs 
Worms under the skin 
Wound up 
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Appendix I: Author proofs of the published paper co-authored by the thesis author during 
the period of PhD candidature 
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